Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	peroxisome proliferator activated receptor binding	NCOA6 MED1 NCOR1 ASXL2	4.35e-06	21	107	4	GO:0042975
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	SOX30 IRX3 NR4A1 CREB5 PRDM2 FOSL1 PHOX2A HOXC4 KMT2D NFATC1 NFAT5 GLIS1 NOTCH4	9.40e-06	560	107	13	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	SOX30 IRX3 NR4A1 CREB5 PRDM2 FOSL1 PHOX2A HOXC4 KMT2D NFATC1 NFAT5 GLIS1 NOTCH4	1.05e-05	566	107	13	GO:0001216
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	SALL3 SOX30 ZNF683 IRX3 NR4A1 MED1 CREB5 FOSL1 BMI1 PHOX2A HOXC4 NFATC1 HEY2 ZFHX3 NFAT5 TET3 GLIS1 FOXK1 NOTCH4	4.15e-05	1271	107	19	GO:0000987
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	PDE3A SALL3 SOX30 IRX3 NR4A1 CREB5 PRDM2 FOSL1 PHOX2A HOXC4 KMT2D NFATC1 ZBTB21 HEY2 ZFHX3 TSHZ1 NFAT5 GLIS1 FOXK1 NOTCH4	5.41e-05	1412	107	20	GO:0000981
GeneOntologyMolecularFunction	DNA-binding transcription repressor activity, RNA polymerase II-specific	SOX30 IRX3 PRDM2 NFATC1 ZBTB21 HEY2 ZFHX3 GLIS1 FOXK1	5.64e-05	320	107	9	GO:0001227
GeneOntologyMolecularFunction	DNA-binding transcription repressor activity	SOX30 IRX3 PRDM2 NFATC1 ZBTB21 HEY2 ZFHX3 GLIS1 FOXK1	6.51e-05	326	107	9	GO:0001217
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	SALL3 SOX30 ZNF683 IRX3 NR4A1 MED1 CREB5 PRDM2 FOSL1 BMI1 NCOR1 PHOX2A HOXC4 NFATC1 HEY2 ZFHX3 NFAT5 TET3 GLIS1 FOXK1	8.51e-05	1459	107	20	GO:0000977
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	SALL3 SOX30 ZNF683 IRX3 NR4A1 MED1 CREB5 FOSL1 BMI1 PHOX2A HOXC4 NFATC1 HEY2 ZFHX3 NFAT5 TET3 GLIS1 FOXK1	1.03e-04	1244	107	18	GO:0000978
GeneOntologyMolecularFunction	chromatin binding	TICRR NCOA6 EP400 ZNF683 MED1 MBD6 FOSL1 BMI1 NCOR1 NFATC1 ASXL2 RERE NFAT5	1.62e-04	739	107	13	GO:0003682
GeneOntologyMolecularFunction	nuclear estrogen receptor binding	NCOA6 MED1 NCOR1 CNOT1	1.86e-04	53	107	4	GO:0030331
GeneOntologyMolecularFunction	nuclear retinoic acid receptor binding	NCOA6 MED1 NCOR1 CNOT1	2.15e-04	55	107	4	GO:0042974
GeneOntologyMolecularFunction	phosphatidylinositol bisphosphate phosphatase activity	MTMR4 SYNJ1 INPP5J	3.98e-04	27	107	3	GO:0034593
GeneOntologyMolecularFunction	phosphatidylinositol phosphate phosphatase activity	MTMR4 SYNJ1 INPP5J	5.47e-04	30	107	3	GO:0052866
GeneOntologyMolecularFunction	inositol-1,4,5-trisphosphate 5-phosphatase activity	SYNJ1 INPP5J	7.80e-04	8	107	2	GO:0052658
GeneOntologyMolecularFunction	nuclear thyroid hormone receptor binding	NCOA6 MED1 NCOR1	7.93e-04	34	107	3	GO:0046966
GeneOntologyMolecularFunction	promoter-specific chromatin binding	ZNF683 MED1 FOSL1 BMI1	1.03e-03	83	107	4	GO:1990841
GeneOntologyMolecularFunction	phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity	SYNJ1 INPP5J	1.24e-03	10	107	2	GO:0004439
GeneOntologyMolecularFunction	phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity	MTMR4 SYNJ1	1.52e-03	11	107	2	GO:0052629
GeneOntologyMolecularFunction	phosphatidylinositol-4,5-bisphosphate phosphatase activity	SYNJ1 INPP5J	1.81e-03	12	107	2	GO:0106019
GeneOntologyMolecularFunction	phosphatidylinositol phosphate 5-phosphatase activity	SYNJ1 INPP5J	2.13e-03	13	107	2	GO:0034595
GeneOntologyMolecularFunction	inositol trisphosphate phosphatase activity	SYNJ1 INPP5J	2.48e-03	14	107	2	GO:0046030
GeneOntologyMolecularFunction	phosphatidylinositol-3-phosphate phosphatase activity	MTMR4 SYNJ1	2.48e-03	14	107	2	GO:0004438
GeneOntologyMolecularFunction	phosphatidylinositol monophosphate phosphatase activity	MTMR4 SYNJ1	2.85e-03	15	107	2	GO:0052744
GeneOntologyMolecularFunction	phosphatidylinositol-3,5-bisphosphate phosphatase activity	MTMR4 SYNJ1	3.25e-03	16	107	2	GO:0106018
GeneOntologyMolecularFunction	nuclear receptor binding	NCOA6 NR4A1 MED1 NCOR1 CNOT1	3.36e-03	187	107	5	GO:0016922
GeneOntologyMolecularFunction	nuclear vitamin D receptor binding	NCOA6 MED1	4.12e-03	18	107	2	GO:0042809
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	NCOA6 SOX30 IRX3 NR4A1 MED1 CREB5 PRDM2 FOSL1 PHOX2A HOXC4 KMT2D NFATC1 HEY2 ZFHX3 SMO ASXL2 NFAT5 TET3 GLIS1 NOTCH4	2.75e-05	1390	107	20	GO:0045944
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase II	PHF12 SOX30 IRX3 MED1 PRDM2 BMI1 NCOR1 NFATC1 ZBTB21 HEY2 ZFHX3 SMO ASXL2 CNOT1 GLIS1 FOXK1 NOTCH4	2.88e-05	1053	107	17	GO:0000122
GeneOntologyCellularComponent	chromatin	EP400 PHF12 SOX30 IRX3 NR4A1 MED1 CREB5 FOSL1 BMI1 NCOR1 PHOX2A HOXC4 NFATC1 HEY2 ZFHX3 TNKS1BP1 TSHZ1 NFAT5 SLX4 FOXK1	6.32e-05	1480	108	20	GO:0000785
GeneOntologyCellularComponent	CCR4-NOT complex	TNKS1BP1 CNOT1 CNOT3	7.15e-05	16	108	3	GO:0030014
GeneOntologyCellularComponent	CCR4-NOT core complex	CNOT1 CNOT3	3.91e-04	6	108	2	GO:0030015
Domain	C8	MUC5B FCGBP MUC5AC	3.87e-05	12	107	3	PF08742
Domain	TIL	MUC5B FCGBP MUC5AC	3.87e-05	12	107	3	PF01826
Domain	Unchr_dom_Cys-rich	MUC5B FCGBP MUC5AC	5.01e-05	13	107	3	IPR014853
Domain	C8	MUC5B FCGBP MUC5AC	5.01e-05	13	107	3	SM00832
Domain	TIL_dom	MUC5B FCGBP MUC5AC	6.36e-05	14	107	3	IPR002919
Domain	VWF_type-D	MUC5B FCGBP MUC5AC	9.70e-05	16	107	3	IPR001846
Domain	VWFD	MUC5B FCGBP MUC5AC	9.70e-05	16	107	3	PS51233
Domain	VWD	MUC5B FCGBP MUC5AC	9.70e-05	16	107	3	SM00216
Domain	VWD	MUC5B FCGBP MUC5AC	9.70e-05	16	107	3	PF00094
Domain	VWC_out	MUC5B FCGBP MUC5AC	1.66e-04	19	107	3	SM00215
Domain	NFAT	NFATC1 NFAT5	3.22e-04	5	107	2	IPR008366
Domain	MA3	EIF4G1 EIF4G3	4.80e-04	6	107	2	SM00544
Domain	MA3	EIF4G1 EIF4G3	4.80e-04	6	107	2	PF02847
Domain	Initiation_fac_eIF4g_MI	EIF4G1 EIF4G3	4.80e-04	6	107	2	IPR003891
Domain	DUF3398	DOCK7 DOCK6	4.80e-04	6	107	2	PF11878
Domain	MI	EIF4G1 EIF4G3	4.80e-04	6	107	2	PS51366
Domain	DOCK_C/D_N	DOCK7 DOCK6	4.80e-04	6	107	2	IPR021816
Domain	WxxW_domain	MUC5B MUC5AC	4.80e-04	6	107	2	IPR025155
Domain	Mucin2_WxxW	MUC5B MUC5AC	4.80e-04	6	107	2	PF13330
Domain	IPT	PLXNB2 NFATC1 NFAT5	4.84e-04	27	107	3	SM00429
Domain	Homeodomain-like	EP400 IRX3 NCOR1 PHOX2A HOXC4 ZFHX3 TSHZ1 RERE	6.50e-04	332	107	8	IPR009057
Domain	eIF5C	EIF4G1 EIF4G3	6.70e-04	7	107	2	SM00515
Domain	W2	EIF4G1 EIF4G3	6.70e-04	7	107	2	PF02020
Domain	W2	EIF4G1 EIF4G3	6.70e-04	7	107	2	PS51363
Domain	W2_domain	EIF4G1 EIF4G3	6.70e-04	7	107	2	IPR003307
Domain	TIG	PLXNB2 NFATC1 NFAT5	7.31e-04	31	107	3	PF01833
Domain	IPT	PLXNB2 NFATC1 NFAT5	8.03e-04	32	107	3	IPR002909
Domain	BEACH	WDR81 WDFY3	1.14e-03	9	107	2	PS50197
Domain	Beach	WDR81 WDFY3	1.14e-03	9	107	2	PF02138
Domain	-	WDR81 WDFY3	1.14e-03	9	107	2	1.10.1540.10
Domain	Beach	WDR81 WDFY3	1.14e-03	9	107	2	SM01026
Domain	BEACH_dom	WDR81 WDFY3	1.14e-03	9	107	2	IPR000409
Domain	VWC	MUC5B FCGBP MUC5AC	1.33e-03	38	107	3	SM00214
Domain	MYB_LIKE	EP400 NCOR1 RERE	1.33e-03	38	107	3	PS50090
Domain	MIF4G	EIF4G1 EIF4G3	1.42e-03	10	107	2	SM00543
Domain	RHD_dimer	NFATC1 NFAT5	1.42e-03	10	107	2	IPR032397
Domain	RHD_dimer	NFATC1 NFAT5	1.42e-03	10	107	2	PF16179
Domain	REL_1	NFATC1 NFAT5	1.42e-03	10	107	2	PS01204
Domain	IPPc	SYNJ1 INPP5J	1.42e-03	10	107	2	IPR000300
Domain	MIF4G	EIF4G1 EIF4G3	1.42e-03	10	107	2	PF02854
Domain	-	NFATC1 NFAT5	1.42e-03	10	107	2	2.60.40.340
Domain	IPPc	SYNJ1 INPP5J	1.42e-03	10	107	2	SM00128
Domain	MIF4G-like_typ-3	EIF4G1 EIF4G3	1.42e-03	10	107	2	IPR003890
Domain	NFkB/Dor	NFATC1 NFAT5	1.42e-03	10	107	2	IPR000451
Domain	RHD_DNA_bind_dom	NFATC1 NFAT5	1.42e-03	10	107	2	IPR011539
Domain	RHD_DNA_bind	NFATC1 NFAT5	1.42e-03	10	107	2	PF00554
Domain	REL_2	NFATC1 NFAT5	1.42e-03	10	107	2	PS50254
Domain	Znf_FYVE_PHD	PHF12 KMT2D MTMR4 SYTL3 WDFY3	1.58e-03	147	107	5	IPR011011
Domain	Rho_GTPase_activation_prot	PLXNB2 ARAP3 ARHGAP21 ARHGAP33	1.64e-03	88	107	4	IPR008936
Domain	DHR-1_domain	DOCK7 DOCK6	1.73e-03	11	107	2	IPR027007
Domain	DHR_2	DOCK7 DOCK6	1.73e-03	11	107	2	PS51651
Domain	DHR_1	DOCK7 DOCK6	1.73e-03	11	107	2	PS51650
Domain	DHR-2	DOCK7 DOCK6	1.73e-03	11	107	2	PF06920
Domain	DOCK	DOCK7 DOCK6	1.73e-03	11	107	2	IPR026791
Domain	DOCK_C	DOCK7 DOCK6	1.73e-03	11	107	2	IPR010703
Domain	DOCK-C2	DOCK7 DOCK6	1.73e-03	11	107	2	PF14429
Domain	DHR-2	DOCK7 DOCK6	1.73e-03	11	107	2	IPR027357
Domain	VWF_dom	MUC5B FCGBP MUC5AC	1.78e-03	42	107	3	IPR001007
Domain	SANT	EP400 NCOR1 RERE	2.95e-03	50	107	3	SM00717
Domain	-	EIF4G1 EIF4G3	3.25e-03	15	107	2	1.25.40.180
Domain	MIF4-like	EIF4G1 EIF4G3	3.25e-03	15	107	2	IPR016021
Domain	Glyco_hormone_CN	MUC5B MUC5AC	3.25e-03	15	107	2	IPR006208
Domain	Cys_knot	MUC5B MUC5AC	3.25e-03	15	107	2	PF00007
Domain	SANT/Myb	EP400 NCOR1 RERE	3.30e-03	52	107	3	IPR001005
Domain	CTCK_1	MUC5B MUC5AC	4.69e-03	18	107	2	PS01185
Domain	Znf_RING/FYVE/PHD	PHF12 ZNRF4 BMI1 KMT2D MTMR4 SYTL3 NEURL1 WDFY3	4.90e-03	459	107	8	IPR013083
Domain	RhoGAP	ARAP3 ARHGAP21 ARHGAP33	5.41e-03	62	107	3	SM00324
Domain	RhoGAP	ARAP3 ARHGAP21 ARHGAP33	5.66e-03	63	107	3	PF00620
Pathway	REACTOME_M_DECAY_DEGRADATION_OF_MATERNAL_MRNAS_BY_MATERNALLY_STORED_FACTORS	ZFP36L2 EIF4G1 TNKS1BP1 CNOT1 CNOT3	1.39e-06	33	84	5	M48026
Pathway	REACTOME_DEADENYLATION_OF_MRNA	EIF4G1 TNKS1BP1 CNOT1 CNOT3	1.14e-05	24	84	4	MM15090
Pathway	REACTOME_DEADENYLATION_OF_MRNA	EIF4G1 TNKS1BP1 CNOT1 CNOT3	1.35e-05	25	84	4	M13492
Pathway	KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119	MBD6 BMI1 ASXL2 FOXK1	1.59e-05	26	84	4	M47923
Pathway	REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT	ZFP36L2 EIF4G1 TNKS1BP1 TET3 CNOT1 CNOT3	1.14e-04	128	84	6	M48019
Pathway	REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN	TNKS1BP1 CNOT1 CNOT3	1.56e-04	18	84	3	MM15336
Pathway	REACTOME_CDC42_GTPASE_CYCLE	ARAP3 DOCK7 DOCK6 ARHGAP21 ARHGAP33	2.41e-04	94	84	5	MM15598
Pathway	REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN	TNKS1BP1 CNOT1 CNOT3	2.51e-04	21	84	3	M27634
Pathway	REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY	EIF4G1 TNKS1BP1 CNOT1 CNOT3	2.96e-04	54	84	4	MM15089
Pathway	REACTOME_CDC42_GTPASE_CYCLE	WDR81 ARAP3 DOCK7 DOCK6 ARHGAP21 ARHGAP33	3.22e-04	155	84	6	M41808
Pathway	REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY	EIF4G1 TNKS1BP1 CNOT1 CNOT3	3.40e-04	56	84	4	M839
Pathway	REACTOME_RAC1_GTPASE_CYCLE	ARAP3 DOCK7 NHS DOCK6 ARHGAP21 ARHGAP33	6.13e-04	175	84	6	MM15599
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TANC2 NCOA6 TBKBP1 EP400 CTC1 PHF12 KSR2 MBD6 PLXNB2 NCOR1 KMT2D ARAP3 SYNJ1 NFATC1 ZFP36L2 EIF4G1 NAV1 RIPOR1 TNKS1BP1 WDFY3 DOCK6 LTBP4 IL4R ARHGAP21 FOXK1 ARHGAP33	9.99e-16	1105	111	26	35748872
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TANC2 NCOA6 KIF26B USP43 TAB3 VPS13D MTMR4 SYNJ1 ZFP36L2 NEURL1 EIF4G1 ZBTB21 DOCK7 NAV1 FMN2 NHS TNKS1BP1 EIF4G3 DOCK6 ARHGAP21 WNK4 FOXK1	4.19e-14	861	111	22	36931259
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	PHF12 PRDM2 NCOR1 KMT2D SYNJ1 ZBTB21 DOCK7 NAV1 ZFHX3 TNKS1BP1 RERE TACC3 CNOT1 ARHGAP21	7.72e-11	418	111	14	34709266
Pubmed	A census of human transcription factors: function, expression and evolution.	SOX30 IRX3 TSC22D2 NR4A1 CREB5 PRDM2 FOSL1 PHOX2A HOXC4 KMT2D NFATC1 ZFP36L2 HEY2 ZFHX3 TSHZ1 RERE NFAT5 GLIS1 FOXK1	8.39e-11	908	111	19	19274049
Pubmed	Interaction network of human early embryonic transcription factors.	NCOA6 TBKBP1 EP400 PHF12 MBD6 PRDM2 NCOR1 KMT2D ZFHX3 ASXL2 RERE SLX4 FOXK1	1.11e-10	351	111	13	38297188
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	NCOA6 EP400 PHF12 MED1 NCOR1 KMT2D ZBTB21 SUGP1 RERE FOXK1	1.62e-08	268	111	10	33640491
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NCOA6 EP400 PHF12 MED1 PRDM2 NCOR1 KMT2D EIF4G1 ZBTB21 AFF1 RIPOR1 TNKS1BP1 RERE TACC3 CNOT3	2.67e-08	774	111	15	15302935
Pubmed	Th2 cytokines orchestrate the secretion of MUC5AC and MUC5B in IL-5-positive chronic rhinosinusitis with nasal polyps.	MUC5B MUC5AC IL4R	3.16e-08	3	111	3	29802623
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	TANC2 TICAM1 WDR81 PLEKHA6 NR4A1 SAPCD2 ARAP3 ZFP36L2 DOCK7 SUGP1 RIPOR1 TNKS1BP1 DOCK6 CNOT1 ARHGAP21 CNOT3 FOXK1	3.40e-08	1038	111	17	26673895
Pubmed	Human transcription factor protein interaction networks.	NCOA6 EP400 PHF12 MBD6 TAB3 PRDM2 NCOR1 KMT2D STAU2 EIF4G1 ZBTB21 SUGP1 ZFHX3 ASXL2 RERE CNOT1 CNOT3 SLX4 FOXK1	1.30e-07	1429	111	19	35140242
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	SOX30 IRX3 NR4A1 CREB5 FOSL1 PHOX2A HOXC4 NFATC1 HEY2 NFAT5 GLIS1 FOXK1	1.84e-07	544	111	12	28473536
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	NCOA6 EP400 MED1 NCOR1 KMT2D FOXK1	2.85e-07	83	111	6	28794006
Pubmed	Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy.	NCOA6 KMT2D ASXL2 FOXK1	4.58e-07	20	111	4	29785026
Pubmed	T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.	NCOA6 NR4A1 MED1 NCOR1	4.58e-07	20	111	4	11877444
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	EP400 SNX19 DOCK7 NAV1 RIPOR1 ASXL2 RERE NFAT5 TET3 ARHGAP21	7.78e-07	407	111	10	12693553
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	NCOA6 EP400 PPFIBP2 TSC22D2 BMI1 NCOR1 AFF1 TSHZ1 EIF4G3 WNK4	1.28e-06	430	111	10	35044719
Pubmed	Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription.	NCOA6 MED1 TNKS1BP1 CNOT1 CNOT3	1.32e-06	59	111	5	28813667
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NCOA6 EP400 MED1 TAB3 NCOR1 KMT2D SYNJ1 DOCK7 TNKS1BP1 TACC3 CNOT1	1.57e-06	549	111	11	38280479
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	EP400 MED1 NCOR1 STAU2 EIF4G1 ZBTB21 SUGP1 TNKS1BP1 SLX4 FOXK1	1.70e-06	444	111	10	34795231
Pubmed	Tie2 regulates endocardial sprouting and myocardial trabeculation.	ROBO4 IRX3 ARAP3 NFATC1 HEY2	2.69e-06	68	111	5	31112136
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	NCOA6 NCOR1 ZFP36L2 EIF4G1 EIF4G3 CNOT1	2.89e-06	123	111	6	26912792
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	KIF26B VPS13D STAU2 DOCK7 NHS TNKS1BP1 ARHGAP21	5.12e-06	209	111	7	36779422
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	PDE3A PLEKHA6 MED1 NCOR1 STAU2 EIF4G1 NHS TNKS1BP1 TACC3 EIF4G3	5.12e-06	503	111	10	16964243
Pubmed	Depletion of mammalian CCR4b deadenylase triggers elevation of the p27Kip1 mRNA level and impairs cell growth.	TNKS1BP1 CNOT1 CNOT3	6.82e-06	12	111	3	17452450
Pubmed	Human Ccr4-Not complexes contain variable deadenylase subunits.	TNKS1BP1 CNOT1 CNOT3	6.82e-06	12	111	3	19558367
Pubmed	Reconstitution of recombinant human CCR4-NOT reveals molecular insights into regulated deadenylation.	TNKS1BP1 CNOT1 CNOT3	6.82e-06	12	111	3	31320642
Pubmed	Biological, clinical and population relevance of 95 loci for blood lipids.	PGS1 PDE3A DOCK7 SUGP1 AFF1 DOCK6	7.78e-06	146	111	6	20686565
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PLXNB2 NCOR1 MTMR4 SYNJ1 WDFY3	9.07e-06	87	111	5	12465718
Pubmed	Foxp1/4 control epithelial cell fate during lung development and regeneration through regulation of anterior gradient 2.	MUC5B HEY2 MUC5AC NOTCH4	9.08e-06	41	111	4	22675208
Pubmed	Cloning and analysis of cDNA encoding a major airway glycoprotein, human tracheobronchial mucin (MUC5).	MUC5B MUC5AC	1.01e-05	2	111	2	7513696
Pubmed	The association between MUC5AC and MUC5B genes expression and remodeling progression in severe neutrophilic asthma: A direct relationship.	MUC5B MUC5AC	1.01e-05	2	111	2	37146737
Pubmed	MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.	MUC5B MUC5AC	1.01e-05	2	111	2	14988081
Pubmed	Mucin glycosylation changes in cystic fibrosis lung disease are not manifest in submucosal gland secretions.	MUC5B MUC5AC	1.01e-05	2	111	2	15563276
Pubmed	The expression of MUC5AC and MUC5B mucin genes in the mucosa of chronic rhinosinusitis and nasal polyposis.	MUC5B MUC5AC	1.01e-05	2	111	2	17621824
Pubmed	Muc5b is required for airway defence.	MUC5B MUC5AC	1.01e-05	2	111	2	24317696
Pubmed	Macrophages are related to goblet cell hyperplasia and induce MUC5B but not MUC5AC in human bronchus epithelial cells.	MUC5B MUC5AC	1.01e-05	2	111	2	22391959
Pubmed	Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules.	MUC5B MUC5AC	1.01e-05	2	111	2	35776514
Pubmed	Retinoblastoma protein-interacting zinc finger 1 (RIZ1) participates in RANKL-induced osteoclast formation via regulation of NFATc1 expression.	PRDM2 NFATC1	1.01e-05	2	111	2	20417662
Pubmed	The ocular surface phenotype of Muc5ac and Muc5b null mice.	MUC5B MUC5AC	1.01e-05	2	111	2	24327612
Pubmed	The anti-leukemic effect of a novel histone deacetylase inhibitor MCT-1 and 5-aza-cytidine involves augmentation of Nur77 and inhibition of MMP-9 expression.	NR4A1 MMP9	1.01e-05	2	111	2	19148494
Pubmed	The role of polycomb group protein Bmi-1 and Notch4 in breast cancer stem cell inhibition by benzyl isothiocyanate.	BMI1 NOTCH4	1.01e-05	2	111	2	25663545
Pubmed	Gel-forming mucins form distinct morphologic structures in airways.	MUC5B MUC5AC	1.01e-05	2	111	2	28607090
Pubmed	Autism-Misregulated eIF4G Microexons Control Synaptic Translation and Higher Order Cognitive Functions.	EIF4G1 EIF4G3	1.01e-05	2	111	2	31999954
Pubmed	Muc5b is mainly expressed and sialylated in the nasal olfactory epithelium whereas Muc5ac is exclusively expressed and fucosylated in the nasal respiratory epithelium.	MUC5B MUC5AC	1.01e-05	2	111	2	31030254
Pubmed	The role of NFAT transcription factors in integrin-mediated carcinoma invasion.	NFATC1 NFAT5	1.01e-05	2	111	2	12080349
Pubmed	LPS-stimulated MUC5AC production involves Rac1-dependent MMP-9 secretion and activation in NCI-H292 cells.	MMP9 MUC5AC	1.01e-05	2	111	2	19501047
Pubmed	The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium.	MUC5B MUC5AC	1.01e-05	2	111	2	23527003
Pubmed	Up-regulation of MUC5AC and MUC5B mucin genes in nasopharyngeal respiratory mucosa and selective up-regulation of MUC5B in middle ear in pediatric otitis media with effusion.	MUC5B MUC5AC	1.01e-05	2	111	2	16540890
Pubmed	eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation.	EIF4G1 EIF4G3	1.01e-05	2	111	2	10872469
Pubmed	Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma.	MUC5B MUC5AC	1.01e-05	2	111	2	27845589
Pubmed	Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease.	MUC5B MUC5AC	1.01e-05	2	111	2	27435107
Pubmed	Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs.	MUC5B MUC5AC	1.01e-05	2	111	2	26871672
Pubmed	Rhinovirus-induced MMP-9 expression is dependent on Fra-1, which is modulated by formoterol and dexamethasone.	FOSL1 MMP9	1.01e-05	2	111	2	22461694
Pubmed	In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model.	MUC5B MUC5AC	1.01e-05	2	111	2	11587997
Pubmed	Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma.	MUC5B MUC5AC	1.01e-05	2	111	2	34656442
Pubmed	Regulation of high glucose-mediated mucin expression by matrix metalloproteinase-9 in human airway epithelial cells.	MMP9 MUC5AC	1.01e-05	2	111	2	25704757
Pubmed	Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.	MUC5B MUC5AC	1.01e-05	2	111	2	34058148
Pubmed	Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9.	FOSL1 MMP9	1.01e-05	2	111	2	22514348
Pubmed	C-Mannosylation of MUC5AC and MUC5B Cys subdomains.	MUC5B MUC5AC	1.01e-05	2	111	2	14718370
Pubmed	Mucin production during prenatal and postnatal murine lung development.	MUC5B MUC5AC	1.01e-05	2	111	2	21653907
Pubmed	MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium.	MUC5B MUC5AC	1.01e-05	2	111	2	36427316
Pubmed	Metalloproteinases mediate mucin 5AC expression by epidermal growth factor receptor activation.	MMP9 MUC5AC	1.01e-05	2	111	2	15531749
Pubmed	Mucin deficiency causes functional and structural changes of the ocular surface.	MUC5B MUC5AC	1.01e-05	2	111	2	23272068
Pubmed	Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B.	MUC5B MUC5AC	1.01e-05	2	111	2	27729120
Pubmed	Subcellular localization of ATBF1 regulates MUC5AC transcription in gastric cancer.	ZFHX3 MUC5AC	1.01e-05	2	111	2	17330845
Pubmed	De novo NUF2 variant in a novel inherited bone marrow failure syndrome including microcephaly and renal hypoplasia.	MUC5B MUC5AC	1.01e-05	2	111	2	36111525
Pubmed	Normal murine respiratory tract has its mucus concentrated in clouds based on the Muc5b mucin.	MUC5B MUC5AC	1.01e-05	2	111	2	32348677
Pubmed	Peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP) but not PPAR-interacting protein (PRIP) is required for nuclear translocation of constitutive androstane receptor in mouse liver.	NCOA6 MED1	1.01e-05	2	111	2	16828057
Pubmed	Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis.	MUC5B MUC5AC	1.01e-05	2	111	2	24332705
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	TBKBP1 CDCP1 EIF4G1 NAV1 TNKS1BP1 TACC3 CNOT1 FOXK1	1.19e-05	332	111	8	37433992
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TANC2 KSR2 WDR81 NCOR1 SYNJ1 EIF4G1 ZBTB21 DOCK7 NAV1 WDFY3 TACC3 CNOT1 ARHGAP21	1.28e-05	963	111	13	28671696
Pubmed	ETS factors regulate Vegf-dependent arterial specification.	HEY2 SMO NOTCH4	1.40e-05	15	111	3	23830865
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	NCOA6 EP400 MED1 NCOR1 KMT2D ZFP36L2 TNKS1BP1 FOXK1	1.45e-05	341	111	8	32971831
Pubmed	Control of spinal motor neuron terminal differentiation through sustained Hoxc8 gene activity.	IRX3 CREB5 HOXC4 TSHZ1	1.86e-05	49	111	4	35315772
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	TBKBP1 EP400 NCOR1 SYNJ1 NFATC1 NAV1 TNKS1BP1 CNOT3 SLX4 FOXK1	1.98e-05	588	111	10	38580884
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	TANC2 TBKBP1 PCARE MED1 EFHC2 ZFP36L2 ZBTB21 DOCK7 NAV1 RIPOR1 TNKS1BP1 MUC5AC CNOT1 FOXK1 MAST3	2.04e-05	1321	111	15	27173435
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	TBKBP1 PPFIBP2 KSR2 HOXC4 NFATC1 NAV1 AFF1 RIPOR1 ZFHX3 RERE EIF4G3 DOCK6 NFAT5 TET3 CNOT1 GLIS1	2.07e-05	1489	111	16	28611215
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	TANC2 CDAN1 NCOR1 SYNJ1 STAU2 FMN2 NFAT5 INPP5J MAST3	2.26e-05	475	111	9	31040226
Pubmed	Cooperative cobinding of synthetic and natural ligands to the nuclear receptor PPARγ.	MED1 NCOR1	3.02e-05	3	111	2	30575522
Pubmed	[Effect of osmotic response element binding protein on mucus secretion with hypertonicity in human airway epithelial cells].	NFAT5 MUC5AC	3.02e-05	3	111	2	21418859
Pubmed	Structural characterization of the Z RING-eIF4E complex reveals a distinct mode of control for eIF4E.	EIF4G1 EIF4G3	3.02e-05	3	111	2	20212144
Pubmed	High-Mobility Group Box 1 Upregulates MUC5AC and MUC5B Expression in Primary Airway Epithelial Cells.	MUC5B MUC5AC	3.02e-05	3	111	2	29286856
Pubmed	Fra-1 and Stat3 synergistically regulate activation of human MMP-9 gene.	FOSL1 MMP9	3.02e-05	3	111	2	17572495
Pubmed	Nebulized Menthol Impairs Mucociliary Clearance via TRPM8 and MUC5AC/MUC5B in Primary Airway Epithelial Cells.	MUC5B MUC5AC	3.02e-05	3	111	2	36675209
Pubmed	Structure and assembly of the NOT module of the human CCR4-NOT complex.	CNOT1 CNOT3	3.02e-05	3	111	2	24121232
Pubmed	Nuclear receptor coactivator 6 promotes HTR-8/SVneo cell invasion and migration by activating NF-κB-mediated MMP9 transcription.	NCOA6 MMP9	3.02e-05	3	111	2	32790097
Pubmed	Cnot1, Cnot2, and Cnot3 maintain mouse and human ESC identity and inhibit extraembryonic differentiation.	CNOT1 CNOT3	3.02e-05	3	111	2	22367759
Pubmed	Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production.	MMP9 MUC5AC	3.02e-05	3	111	2	18006877
Pubmed	Resistin upregulates MUC5AC/B mucin gene expression in human airway epithelial cells.	MUC5B MUC5AC	3.02e-05	3	111	2	29604272
Pubmed	An interaction of heart disease-associated proteins POPDC1/2 with XIRP1 in transverse tubules and intercalated discs.	XIRP1 POPDC2	3.02e-05	3	111	2	33261556
Pubmed	A newly identified N-terminal amino acid sequence of human eIF4G binds poly(A)-binding protein and functions in poly(A)-dependent translation.	EIF4G1 EIF4G3	3.02e-05	3	111	2	9857202
Pubmed	Aquaporin 5 expression increases mucin production in lung adenocarcinoma.	MUC5B MUC5AC	3.02e-05	3	111	2	21455588
Pubmed	Muc5ac: a critical component mediating the rejection of enteric nematodes.	MUC5AC IL4R	3.02e-05	3	111	2	21502330
Pubmed	NFATc1 mediates Toll-like receptor-independent innate immune responses during Trypanosoma cruzi infection.	TICAM1 NFATC1	3.02e-05	3	111	2	19609356
Pubmed	Expression of leptin receptor in nasal polyps: leptin as a mucosecretagogue.	MUC5B MUC5AC	3.02e-05	3	111	2	20422702
Pubmed	Orphan nuclear receptor Nur77 promotes colorectal cancer invasion and metastasis by regulating MMP-9 and E-cadherin.	NR4A1 MMP9	3.02e-05	3	111	2	25064356
Pubmed	Peroxisome-proliferator-activated receptor-binding protein (PBP) is essential for the growth of active Notch4-immortalized mammary epithelial cells by activating SOX10 expression.	MED1 NOTCH4	3.02e-05	3	111	2	19852756
Pubmed	Mucin gene polymorphisms in otitis media patients.	MUC5B MUC5AC	3.02e-05	3	111	2	19718741
Pubmed	The CCR4-NOT complex contributes to repression of Major Histocompatibility Complex class II transcription.	CNOT1 CNOT3	3.02e-05	3	111	2	28615693
Pubmed	Interleukin-33 induces mucin gene expression and goblet cell hyperplasia in human nasal epithelial cells.	MUC5B MUC5AC	3.02e-05	3	111	2	27776277
Interaction	YWHAH interactions	TANC2 TICRR NCOA6 KIF26B PPFIBP2 KSR2 USP43 MED1 TAB3 VPS13D MTMR4 SYNJ1 ZFP36L2 EIF4G1 ZBTB21 DOCK7 NAV1 FMN2 NHS TNKS1BP1 EIF4G3 DOCK6 ARHGAP21 FOXK1 MAST3	7.22e-10	1102	109	25	int:YWHAH
Interaction	TOP3B interactions	TANC2 NCOA6 TBKBP1 EP400 CTC1 PHF12 KSR2 MBD6 PLXNB2 NCOR1 KMT2D ARAP3 SYNJ1 NFATC1 ZFP36L2 EIF4G1 NAV1 RIPOR1 TNKS1BP1 WDFY3 DOCK6 LTBP4 CNOT1 IL4R ARHGAP21 FOXK1 ARHGAP33	1.27e-08	1470	109	27	int:TOP3B
Interaction	VASP interactions	XIRP1 PCARE NR4A1 JMY BMI1 SYNJ1 FMN2 NHS TNKS1BP1 TACC3 ARHGAP21 FOXK1	6.60e-08	294	109	12	int:VASP
Interaction	YWHAQ interactions	TANC2 TICRR NCOA6 PDE3A KIF26B PPFIBP2 KSR2 USP43 MED1 TAB3 VPS13D MTMR4 NFATC1 ZFP36L2 EIF4G1 ZBTB21 DOCK7 NAV1 NHS ARHGAP21 WNK4 FOXK1	1.14e-07	1118	109	22	int:YWHAQ
Interaction	SFN interactions	TANC2 NCOA6 KIF26B PPFIBP2 GRB7 TAB3 BMI1 MTMR4 ZFP36L2 EIF4G1 ZBTB21 DOCK7 NAV1 FMN2 NHS TNS4 ARHGAP21	1.81e-07	692	109	17	int:SFN
Interaction	YWHAG interactions	TANC2 TICRR NCOA6 KIF26B PPFIBP2 KSR2 USP43 TAB3 VPS13D MTMR4 SYNJ1 ZFP36L2 EIF4G1 ZBTB21 DOCK7 NAV1 FMN2 NHS EIF4G3 ARHGAP21 FOXK1 MAST3	7.44e-07	1248	109	22	int:YWHAG
Interaction	HDAC1 interactions	EP400 PHF12 USP43 NR4A1 FOSL1 NCOR1 KMT2D SYNJ1 NFATC1 ZBTB21 DOCK7 HEY2 NAV1 AFF1 ZFHX3 TNKS1BP1 RERE TACC3 ARHGAP21 FOXK1	1.80e-06	1108	109	20	int:HDAC1
Interaction	YWHAZ interactions	TANC2 TICRR KIF26B PPFIBP2 KSR2 USP43 NR4A1 TAB3 NCOR1 VPS13D MTMR4 ADRA2B ZFP36L2 ZBTB21 DOCK7 NAV1 NHS ASXL2 WDFY3 ARHGAP21 FOXK1 MAST3	1.86e-06	1319	109	22	int:YWHAZ
Interaction	HNF4A interactions	NCOA6 EP400 PHF12 MED1 BMI1 NCOR1 KMT2D ZBTB21 ASXL2 SLX4	2.47e-06	275	109	10	int:HNF4A
Interaction	KDM1A interactions	EP400 PHF12 PRDM2 BMI1 NCOR1 KMT2D SYNJ1 FAM161A ZBTB21 DOCK7 NAV1 ZFHX3 TNKS1BP1 RERE TACC3 CNOT1 ARHGAP21 CNOT3	2.85e-06	941	109	18	int:KDM1A
Interaction	EGR2 interactions	NCOA6 EP400 PHF12 NCOR1 KMT2D NFATC1 ZFHX3 RERE	4.18e-06	171	109	8	int:EGR2
Interaction	NUP43 interactions	NCOA6 EP400 PHF12 PRDM2 NCOR1 KMT2D ZFP36L2 EIF4G1 ZFHX3 ASXL2 RERE EIF4G3 CNOT1 SLX4	7.00e-06	625	109	14	int:NUP43
Interaction	YWHAE interactions	TANC2 TICRR KIF26B PPFIBP2 KSR2 USP43 MBD6 TAB3 BMI1 MTMR4 ZFP36L2 ZBTB21 DOCK7 NAV1 NHS ASXL2 ARHGAP21 FOXK1 ARHGAP33 MAST3	1.18e-05	1256	109	20	int:YWHAE
Interaction	ANXA2R interactions	TNKS1BP1 CNOT1 CNOT3	1.26e-05	9	109	3	int:ANXA2R
Interaction	GATA2 interactions	NCOA6 MED1 BMI1 NCOR1 KMT2D NFATC1 ZFHX3 ASXL2	1.27e-05	199	109	8	int:GATA2
Interaction	FEV interactions	NCOA6 EP400 PHF12 NCOR1 KMT2D ZFHX3 ASXL2 FOXK1	1.47e-05	203	109	8	int:FEV
Interaction	WWTR1 interactions	NCOA6 EP400 TAB3 NCOR1 KMT2D SYNJ1 NFATC1 DOCK7 TNKS1BP1 TACC3 CNOT1	1.82e-05	422	109	11	int:WWTR1
Interaction	HCFC1 interactions	NCOA6 EP400 MBD6 NCOR1 KMT2D ASXL2 RERE SLX4 FOXK1	3.07e-05	293	109	9	int:HCFC1
Interaction	FOXK2 interactions	TANC2 MBD6 NCOR1 KMT2D MTMR4 NFATC1 ASXL2 FOXK1	3.08e-05	225	109	8	int:FOXK2
Interaction	KLF3 interactions	EP400 PHF12 MBD6 PRDM2 NCOR1 KMT2D ZFHX3 FOXK1	3.38e-05	228	109	8	int:KLF3
Interaction	FOXK1 interactions	TANC2 MBD6 BMI1 NCOR1 MTMR4 NFATC1 ASXL2 FOXK1	4.58e-05	238	109	8	int:FOXK1
Interaction	FHL2 interactions	EP400 SOX30 BMI1 NCOR1 TNKS1BP1 ASXL2 NFAT5 CNOT1 CNOT3 FOXK1	5.80e-05	396	109	10	int:FHL2
Interaction	PHF21A interactions	PHF12 KMT2D SYNJ1 DOCK7 NAV1 ZFHX3 TNKS1BP1 TACC3 ARHGAP21	1.03e-04	343	109	9	int:PHF21A
Interaction	YWHAB interactions	TANC2 TICRR KIF26B KSR2 USP43 VPS13D MTMR4 ZFP36L2 EIF4G1 ZBTB21 DOCK7 NAV1 NHS ARHGAP21 FOXK1 MAST3	1.09e-04	1014	109	16	int:YWHAB
Interaction	MMP7 interactions	TNKS1BP1 MMP9 CNOT1 CNOT3	1.11e-04	46	109	4	int:MMP7
Interaction	MAGEA9 interactions	SALL3 SYNJ1 FAM161A SUGP1 TNKS1BP1 CNOT1 CNOT3	1.38e-04	208	109	7	int:MAGEA9
Interaction	NANOS1 interactions	TNKS1BP1 CNOT1 CNOT3	1.64e-04	20	109	3	int:NANOS1
Interaction	PAX6 interactions	NCOA6 EP400 PHF12 NCOR1 KMT2D SYNJ1 ZFHX3 ASXL2 FOXK1	1.68e-04	366	109	9	int:PAX6
Interaction	MEX3A interactions	TBKBP1 CDCP1 EIF4G1 NAV1 TNKS1BP1 TACC3 CNOT1 CNOT3 FOXK1	2.40e-04	384	109	9	int:MEX3A
Interaction	KDM6A interactions	NCOA6 BMI1 KMT2D ASXL2 RERE FOXK1	2.52e-04	162	109	6	int:KDM6A
Interaction	AR interactions	NCOA6 EP400 PHF12 GRB7 MED1 BMI1 NCOR1 KMT2D ALDH16A1 ZBTB21 SUGP1 ZFHX3 TNS4 RERE FOXK1	2.89e-04	992	109	15	int:AR
GeneFamily	Nuclear factors of activated T-cells	NFATC1 NFAT5	1.82e-04	5	78	2	665
GeneFamily	Phosphoinositide phosphatases	MTMR4 SYNJ1 INPP5J	3.50e-04	32	78	3	1079
GeneFamily	WD repeat domain containing\|BEACH domain containing	WDR81 WDFY3	6.49e-04	9	78	2	1230
GeneFamily	CCR4-NOT transcription complex	CNOT1 CNOT3	9.85e-04	11	78	2	1023
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	EP400 NCOR1 RERE	1.55e-03	53	78	3	532
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZFHX3 TSHZ1	1.86e-03	15	78	2	529
GeneFamily	CD molecules\|Mucins	MUC5B MUC5AC	3.66e-03	21	78	2	648
GeneFamily	Ataxins\|Trinucleotide repeat containing	EP400 KMT2D	5.17e-03	25	78	2	775
Coexpression	GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN	GRB7 MBD6 CDCP1 KMT2D TNS4 MMP9 NFAT5 MAST3	2.17e-06	199	111	8	M7319
ToppCell	human_hepatoblastoma-Endothelial_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	TANC2 NID2 CREB5 NFATC1 NAV1 DOCK6 NOTCH4	5.03e-07	190	111	7	8d6ef93d69e96cd6921816d152bea3b0710cf147
ToppCell	Adult-Epithelial-lung_goblet_cell-D175\|Adult / Lineage, Cell type, age group and donor	KIF26B MUC5B PLEKHA6 NR4A1 NHS MUC5AC	3.53e-06	164	111	6	6e6aedb61f8e195d52e028fdda750a29bb14e57e
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TBKBP1 KIF26B MUC5B FCGBP MUC5AC INPP5J	3.79e-06	166	111	6	60060b03f2abfa3cc08107ab5a9f578e60e4ae16
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TBKBP1 KIF26B MUC5B FCGBP MUC5AC INPP5J	3.79e-06	166	111	6	ec9161d388db5a257b8d125c14f9dd911d5d5d4a
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TBKBP1 KIF26B MUC5B FCGBP MUC5AC INPP5J	3.79e-06	166	111	6	4586d6725403f879fc96f67be579022587ce1906
ToppCell	droplet-Lung-21m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TANC2 CREB5 LRRC25 NEURL1 ZFHX3 TNS4	4.06e-06	168	111	6	aaafa7243c44e6852d92e3445335fc4a1018f416
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SALL3 USP43 TSC22D2 FCGBP WNK4 INPP5J	4.80e-06	173	111	6	0c74bdb40e635d906fd180412c23bf7fed61621e
ToppCell	COVID-19_Mild-Neu_3\|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients	TSC22D2 CDCP1 KMT2D NHS SLX4 MAST3	5.30e-06	176	111	6	2049767fd591045cfcf5b1071d80798e52843f27
ToppCell	renal_papilla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	KIF26B KSR2 SYTL3 NAV1 EIF4G3 NFAT5	6.03e-06	180	111	6	49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4
ToppCell	367C-Endothelial_cells-Endothelial-B_(Artery)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PDE3A PLEKHA6 POPDC2 ZBTB21 HEY2 LTBP4	7.05e-06	185	111	6	b57dae20c21f984edd2acee4344d86f033108ebf
ToppCell	367C-Endothelial_cells-Endothelial-B_(Artery)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PDE3A PLEKHA6 POPDC2 ZBTB21 HEY2 LTBP4	7.05e-06	185	111	6	d3b054d203e575c1bb5455aa7a2e551a0957a760
ToppCell	droplet-Bladder-Unstain-18m-Endothelial-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 TBKBP1 IRX3 PHOX2A ARAP3 NOTCH4	7.27e-06	186	111	6	e3a14f3ccadbf3211822c67b8956ee01f563307a
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TANC2 EPHX2 HEY2 TNKS1BP1 LTBP4 WNK4	7.27e-06	186	111	6	c116cc9f41971622264434ebe29d18e719b0ae19
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3A PPFIBP2 POPDC2 HEY2 ZFHX3 GLIS1	7.27e-06	186	111	6	a95744b8649096bd7cfc3591a02841fa411085b3
ToppCell	droplet-Pancreas-Exocrine-24m-Endothelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 NID2 IRX3 ARAP3 LTBP4 NOTCH4	7.50e-06	187	111	6	a178b1fed80a0bf83aedb6262493ee17374734b5
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 NID2 PDE3A USP43 SYTL3 NHS	7.50e-06	187	111	6	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	droplet-Pancreas-Exocrine-24m-Endothelial-endothelial_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 NID2 IRX3 ARAP3 LTBP4 NOTCH4	7.50e-06	187	111	6	e60cbccf5842f25123fd34b9475759b7424b32e9
ToppCell	droplet-Pancreas-Exocrine-24m-Endothelial-endothelial_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 NID2 IRX3 ARAP3 LTBP4 NOTCH4	7.50e-06	187	111	6	2b8eda2812be0be68a6f01aa4038925d3d5b1e65
ToppCell	droplet-Mammary_Gland-nan-21m-Endothelial-endothelial_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 TBKBP1 ARAP3 DOCK6 LTBP4 NOTCH4	7.97e-06	189	111	6	8ced0381ea042ba47680a02b617a2368fa2c54c8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A ARAP3 HEY2 NAV1 LTBP4 NOTCH4	7.97e-06	189	111	6	12b6f1c3bf526b90e112374bf937701f645c5780
ToppCell	droplet-Mammary_Gland-nan-21m-Endothelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 TBKBP1 ARAP3 DOCK6 LTBP4 NOTCH4	7.97e-06	189	111	6	403a82bb416aed13b9d31411ad17bdc4ce2a95fb
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ROBO4 ARAP3 TSHZ1 DOCK6 IL4R NOTCH4	8.46e-06	191	111	6	2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982
ToppCell	human_hepatoblastoma-Endothelial_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	TANC2 CREB5 NFATC1 NAV1 DOCK6 NOTCH4	8.72e-06	192	111	6	e09f609fed033a25baacaf4a07bbbae1076da366
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 SALL3 ARAP3 NAV1 DOCK6 LTBP4	8.98e-06	193	111	6	826b8dd801298b3e0cd76232feae5a14026b8806
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TANC2 PLEKHA6 AFF1 RERE EIF4G3 NFAT5	8.98e-06	193	111	6	779276e775cb2492e8dd36436295a536084a6415
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD\|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	USP43 NR4A1 FOSL1 SYTL3 NHS IL4R	8.98e-06	193	111	6	ca7c0a4ceb05bced90f6cdc53d278e547fb241e9
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 SALL3 ARAP3 NAV1 DOCK6 LTBP4	8.98e-06	193	111	6	87d3a577d37fb0cb4b6313c596310de452bc3872
ToppCell	Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ROBO4 KIF26B ARAP3 NAV1 DOCK6 NOTCH4	8.98e-06	193	111	6	ad2df9b77999780860141be6ec366afc0172a331
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A ARAP3 HEY2 NAV1 LTBP4 NOTCH4	8.98e-06	193	111	6	0b328f725f6feba263783eaca60c142e80df90f3
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ROBO4 ARAP3 NAV1 DOCK6 IL4R NOTCH4	9.25e-06	194	111	6	e55dc30e200c9f576804acb642175eb4fa9146b5
ToppCell	COVID-19-kidney-PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	ROBO4 ARAP3 NAV1 DOCK6 IL4R NOTCH4	9.52e-06	195	111	6	a436483fec137584611f86b7a498a4dc2aa19cd3
ToppCell	BAL-Control\|BAL / Compartment, Disease Groups and Clusters	TANC2 NR4A1 CREB5 FCGBP ZFP36L2 ZFHX3	9.52e-06	195	111	6	bf940d836a34118a56bc956e6210e310510bca4d
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ROBO4 ARAP3 NAV1 DOCK6 IL4R NOTCH4	9.80e-06	196	111	6	023312af38f816a44b407e0daa32590d953caf99
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	ROBO4 ARAP3 NAV1 DOCK6 IL4R NOTCH4	9.80e-06	196	111	6	b71b197cb92117dd9efaa13de000841901cc4ca8
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ROBO4 ARAP3 NAV1 DOCK6 IL4R NOTCH4	1.01e-05	197	111	6	0f467ef58f0c4dcc00b34b7b9639e03fb3ebe780
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ROBO4 NR4A1 ARAP3 NAV1 DOCK6 NOTCH4	1.01e-05	197	111	6	81718164c9802ee20c860ffbda7e62d5e9a76f16
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ROBO4 ARAP3 NAV1 DOCK6 IL4R NOTCH4	1.04e-05	198	111	6	1378c6d4ceb84b42fdd6556be3296df7a8059e6e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ROBO4 ARAP3 NAV1 DOCK6 IL4R NOTCH4	1.04e-05	198	111	6	451003a21162eeae90739fdb502bb50b362d80c8
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ROBO4 ARAP3 NAV1 DOCK6 IL4R NOTCH4	1.04e-05	198	111	6	440af8f90c7afa1c07000806bcf9110b70f489fb
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ROBO4 IRX3 ARAP3 DOCK6 IL4R NOTCH4	1.07e-05	199	111	6	e6715288a586631676722f2323f0d833431161cf
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate\|5w / Sample Type, Dataset, Time_group, and Cell type.	TANC2 MTMR4 NAV1 ZFHX3 EIF4G3 MAST3	1.10e-05	200	111	6	c92e4fc0442404481fcac623d691dae6215b852d
ToppCell	Control-Endothelial-Endothelial-Activated_Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TSC22D2 CREB5 NAV1 RIPOR1 NOTCH4	1.32e-05	121	111	5	a5962d1c476e6966870832b72d511607e047248b
ToppCell	356C-Myeloid-Macrophage-SPP1+_Macrophage\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	FOSL1 RASGRP1 ZBTB21 NHS TNKS1BP1	1.55e-05	125	111	5	43aa4b77dccf0ea2979218826af16034f2017c3a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SALL3 SAPCD2 NEURL1 VWA5B1 INPP5J	3.16e-05	145	111	5	9964d6d3769be2f35d86268fe044cecd1d5a1616
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KIF26B KSR2 MUC5B RASGRP1 NFAT5	3.84e-05	151	111	5	10da94037225a71844281ddcb395072250a78094
ToppCell	normal_Lymph_Node-Myeloid_cells-mo-Mac\|Myeloid_cells / Location, Cell class and cell subclass	ADRA2B LRRC25 MMP9 TET3 ARHGAP21	4.08e-05	153	111	5	5424494ea1f09542799045a875cc3eac13de5079
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_STALK\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ROBO4 GRB7 IRX3 ARAP3 NOTCH4	4.21e-05	154	111	5	b0735365de153d4586ca17896431d7bd9c7d8eac
ToppCell	BAL-Severe-cDC_4\|Severe / Compartment, Disease Groups and Clusters	SAPCD2 ZFP36L2 NEURL1 NHS ZFHX3	4.76e-05	158	111	5	73f66689ef59f71b14cb7141ca5951cc47fe57c1
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_5\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ROBO4 NR4A1 CRIP3 FOSL1 ZBTB21	5.20e-05	161	111	5	78cc5bc488bc47726195a649946d414e6bfabf94
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Myeloid-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TICAM1 PLXNB2 LRRC25 NHS INPP5J	5.36e-05	162	111	5	b502d6af6868425b5c919740e011330c0d3cf3b8
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_5\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ROBO4 NR4A1 CRIP3 FOSL1 ZBTB21	5.36e-05	162	111	5	0fa93efc9c005d1e649b3f7069ae8641d6e41ed8
ToppCell	3'_v3-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|Lung / Manually curated celltypes from each tissue	POPDC2 SAPCD2 ADRA2B TACC3 ARHGAP33	5.52e-05	163	111	5	47300dec94dc66e965bf71fafff0a9fd24fae968
ToppCell	droplet-Marrow-BM-30m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TICRR NR4A1 SYNJ1 STAU2 TNKS1BP1	5.68e-05	164	111	5	b77995958c938e10a526118f75d78cee72e0b207
ToppCell	facs-Marrow-Granulocytes-24m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NR4A1 PLXNB2 LRRC25 NAV1 GLIS1	5.85e-05	165	111	5	11227bff52eed30b80937fdb1968d0b8e6d30365
ToppCell	facs-Marrow-Granulocytes-24m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NR4A1 PLXNB2 LRRC25 NAV1 GLIS1	5.85e-05	165	111	5	036f9749048e5e50769cc3210339bf4da469215d
ToppCell	severe_influenza-CD4+_CTL\|severe_influenza / disease group, cell group and cell class (v2)	RASGRP1 ZFP36L2 SYTL3 LTBP4 GLIS1	6.37e-05	168	111	5	50697fda702a09d9a621e9f79c2b52d53792dd2a
ToppCell	droplet-Lung-21m-Hematologic-myeloid-interstitial_macrophage\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TANC2 CREB5 LRRC25 NEURL1 TNS4	6.37e-05	168	111	5	06787d4f08ddf052127404a0ea6a85e1b048e206
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PPFIBP2 USP43 NEURL1 TNS4 VWA5B1	6.55e-05	169	111	5	4b3a7b4a497178799b6b2f0b744f5fb752cee31a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PPFIBP2 USP43 NEURL1 TNS4 VWA5B1	6.55e-05	169	111	5	a4fd646b9bf87225131fca530bd6b52df9eaf489
ToppCell	facs-Marrow-T-cells-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPFIBP2 PLXNB2 MTMR4 LRRC25 NAV1	6.73e-05	170	111	5	a78d9789c3e7c84a36e1bd380192d7aba4a4d443
ToppCell	facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPFIBP2 PLXNB2 MTMR4 LRRC25 NAV1	6.73e-05	170	111	5	ff68600b945b3a5437b14e5411b3db800d0ccbe5
ToppCell	5'-Adult-LargeIntestine-Epithelial-goblet-Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KSR2 MUC5B FCGBP NEURL1 WNK4	6.92e-05	171	111	5	48125d825ca2d7ef34564250f5b47d2a579e03c9
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3A PPFIBP2 POPDC2 HEY2 GLIS1	6.92e-05	171	111	5	4ede831aed364cb5271f49a8b09bb6d0452f9b35
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PDE3A NR4A1 ARAP3 DOCK6 NOTCH4	6.92e-05	171	111	5	1597459c971d6befa991d59dc66b41b6a522f797
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ROBO4 ARAP3 NAV1 IL4R NOTCH4	7.31e-05	173	111	5	f193c63cc536d891c9d23043765e320252bb6e65
ToppCell	droplet-Lung-nan-21m-Myeloid-Interstitial_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TANC2 CREB5 NEURL1 ZFHX3 TNS4	7.31e-05	173	111	5	31ea04e65876c42b90245d280f0b6439bfffbace
ToppCell	droplet-Lung-nan-21m-Myeloid-lung_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TANC2 CREB5 NEURL1 ZFHX3 TNS4	7.31e-05	173	111	5	1cff815536f620e32b9805666e1aa711462c2d25
ToppCell	Adult-Endothelial-endothelial_cell_of_artery-D175\|Adult / Lineage, Cell type, age group and donor	PDE3A NR4A1 ARAP3 HEY2 NOTCH4	7.72e-05	175	111	5	0a65ddfa8c2e8efb5b5338cf07661cb78157a23c
ToppCell	COVID-19-Heart-VSMC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE3A NR4A1 HEY2 NHS ZFHX3	7.72e-05	175	111	5	1125f0d3a5b2388fa77a820dea0288e824d84a82
ToppCell	droplet-Kidney-KIDNEY-30m-Mesenchymal-podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTC1 MUC5B SAPCD2 FCGBP STAU2	7.72e-05	175	111	5	31f0fb2e47e357dbf9c15436b7df85b3c370ded7
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	XIRP1 POPDC2 TAB3 CDAN1 SLX4	7.93e-05	176	111	5	4ed73c73972334f6dc4229920205547823252fa0
ToppCell	wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	TANC2 PDE3A ARAP3 HEY2 LTBP4	7.93e-05	176	111	5	52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5B NR4A1 TNKS1BP1 DOCK6 MUC5AC	8.15e-05	177	111	5	a235ff4f37a7622216526191efc4832fb8ed6957
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TANC2 MUC5B NR4A1 MUC5AC ARHGAP21	8.59e-05	179	111	5	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	COVID-19-kidney-AQP1+SLC14A1+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE3A HEY2 NAV1 DOCK6 NOTCH4	8.59e-05	179	111	5	1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ROBO4 KIF26B ARAP3 NAV1 DOCK6	8.82e-05	180	111	5	d8ef44710a77ad0fc03243428e5e1dc4d41200cb
ToppCell	droplet-Liver-nan-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 ARAP3 HEY2 NAV1 LTBP4	9.05e-05	181	111	5	fcc94f04dae98b817ec06b282d2e887804d37ae5
ToppCell	Healthy-multiplets\|World / disease group, cell group and cell class	TANC2 PLEKHA6 CRIP3 NAV1 SMO	9.05e-05	181	111	5	f8dbac3cd500cc8d80853312b00d124c27b8fd85
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KIF26B KSR2 RASGRP1 DOCK7 AFF1	9.05e-05	181	111	5	b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f
ToppCell	droplet-Liver-Npc-21m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 ARAP3 NAV1 LTBP4 NOTCH4	9.29e-05	182	111	5	dc55de945c6f78f32eb3a1b3520835eb8417e068
ToppCell	droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 ARAP3 NAV1 LTBP4 NOTCH4	9.29e-05	182	111	5	010a7364da46101cb5068891fd7bc712ea8f13bd
ToppCell	droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 ARAP3 HEY2 LTBP4 INPP5J	9.53e-05	183	111	5	709a486154b3157427deb3b8886b63ac39ea42dd
ToppCell	droplet-Liver-nan-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 ARAP3 HEY2 LTBP4 INPP5J	9.53e-05	183	111	5	dc06f19f6f80f4c7f13f1f990c1fe0f91ba64ea7
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SALL3 TSC22D2 DOCK7 WNK4 INPP5J	9.53e-05	183	111	5	2f0ee40e69ad1259e56e8ee4b352736900eb8901
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ROBO4 HEY2 SMO LTBP4 NOTCH4	9.78e-05	184	111	5	087666ba949b129c53d7ace40f9e543e3875a7de
ToppCell	3'-GW_trimst-2-LargeIntestine-Epithelial-goblet-Goblet_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MUC5B CDCP1 FCGBP NEURL1 WNK4	9.78e-05	184	111	5	886d2d9bf2fe31207f17e3edc309ef44029924e1
ToppCell	3'-GW_trimst-2-LargeIntestine-Epithelial-goblet\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MUC5B CDCP1 FCGBP NEURL1 WNK4	9.78e-05	184	111	5	936b39377eebea3961d702532779f6cd27953be7
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	CDCP1 CREB5 SYTL3 NHS IL4R	9.78e-05	184	111	5	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KIF26B CREB5 NHS VWA5B1 INPP5J	9.78e-05	184	111	5	7d41784eac0935e77d6bc701f20c693adf998730
ToppCell	droplet-Mammary_Gland-nan-21m-Endothelial-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 ARAP3 DOCK6 LTBP4 NOTCH4	1.00e-04	185	111	5	62cfcb0e2a9e6718e6b200dfbb1a81eaead229b5
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XIRP1 SOX30 EFHC2 ADRA2B HEY2	1.00e-04	185	111	5	30df02fbe2828e3c4f3e5c4cda855e74fb31be39
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231\|Adult / Lineage, Cell type, age group and donor	ROBO4 ARAP3 NAV1 DOCK6 NOTCH4	1.00e-04	185	111	5	07f9f38f0739d7c830641723a38385550ac1ac92
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE3A TSC22D2 FOSL1 NFATC1 AFF1	1.00e-04	185	111	5	eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCell	Control-Epithelial-Basal\|Epithelial / Disease state, Lineage and Cell class	FOSL1 ZFP36L2 NHS TNS4 NOTCH4	1.00e-04	185	111	5	d5d6d13e2f20b54ca55645b9a757b8599f4fd897
ToppCell	Control-Endothelial_cells-Endothelial_cells_(other)\|Control / group, cell type (main and fine annotations)	ROBO4 ARAP3 NAV1 DOCK6 NOTCH4	1.03e-04	186	111	5	c6075fe84226b370c5139066793844ad33ae2db1
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	MED1 VPS13D ASXL2 NFAT5 TET3	1.03e-04	186	111	5	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ROBO4 ARAP3 DOCK6 IL4R NOTCH4	1.05e-04	187	111	5	35c382c0aabd46906113e5db30ea24bb8e658899
ToppCell	droplet-Lung-18m-Endothelial-arterial_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHX2 HEY2 RIPOR1 LTBP4 NOTCH4	1.05e-04	187	111	5	12129e02638c20d9b7c1c6e512d48bfd966e1029
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175\|Adult / Lineage, Cell type, age group and donor	ROBO4 NR4A1 ARAP3 DOCK6 NOTCH4	1.05e-04	187	111	5	f3548817f2fded5978137bb252cb628ac199e4f6
ToppCell	droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHX2 HEY2 RIPOR1 LTBP4 NOTCH4	1.05e-04	187	111	5	83930ef55191eff9006113feaeabb3c2fa21fd05
Drug	0198306-0000 [212631-61-3]; Down 200; 10uM; MCF7; HT_HG-U133A	TICAM1 MUC5B FOSL1 RASGRP1 ZFP36L2 SUGP1 MMP9 LTBP4 IL4R	4.91e-07	195	111	9	7099_DN
Drug	Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A	TBKBP1 PPFIBP2 MUC5B NR4A1 PHOX2A VPS13D ZFP36L2 MUC5AC ARHGAP33	4.91e-07	195	111	9	2875_UP
Drug	Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A	TBKBP1 NR4A1 RIPOR1 RERE LTBP4 IL4R INPP5J ARHGAP33 MAST3	5.35e-07	197	111	9	2766_UP
Drug	CP-690334-01 [459212-38-5]; Down 200; 10uM; MCF7; HT_HG-U133A	TANC2 MED1 ZFP36L2 EIF4G1 SUGP1 DOCK6 NFAT5 MAST3	4.83e-06	193	111	8	3906_DN
Drug	Diltiazem hydrochloride [33286-22-5]; Up 200; 8.8uM; PC3; HT_HG-U133A	ROBO4 KIF26B EFHC2 ZFP36L2 SUGP1 MUC5AC INPP5J MAST3	5.02e-06	194	111	8	6710_UP
Drug	0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A	MUC5B FOSL1 RASGRP1 ZFP36L2 SUGP1 RERE LTBP4 IL4R	5.02e-06	194	111	8	3969_DN
Drug	2-propylpentanoic acid; Down 200; 50uM; HL60; HT_HG-U133A	MED1 FOSL1 NCOR1 ZFP36L2 SUGP1 RERE IL4R MAST3	5.21e-06	195	111	8	1163_DN
Drug	Nifedipine [21829-25-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A	EPHX2 TBKBP1 PRDM2 FOSL1 ZFP36L2 NEURL1 LTBP4 IL4R	5.21e-06	195	111	8	6006_UP
Drug	Ioversol [87771-40-2]; Down 200; 5uM; MCF7; HT_HG-U133A	MUC5B TSC22D2 MED1 FOSL1 VPS13D ZFP36L2 SUGP1 RERE	5.62e-06	197	111	8	3365_DN
Drug	Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; MCF7; HT_HG-U133A	PPFIBP2 FOSL1 VPS13D HOXC4 ZFP36L2 NEURL1 SUGP1 ARHGAP33	5.62e-06	197	111	8	7360_UP
Drug	Nifurtimox [23256-30-6]; Up 200; 14uM; MCF7; HT_HG-U133A	PPFIBP2 PHOX2A SUGP1 RERE LTBP4 INPP5J ARHGAP33 MAST3	6.28e-06	200	111	8	4953_UP
Drug	fullerene C60	GDF5 NCOA6 TBKBP1 MUC5B IRX3 POPDC2 MBD6 PLXNB2 TXNDC11 FOSL1 NCOR1 PHOX2A ADRA2B ZFP36L2 ALDH16A1 ZBTB21 RIPOR1 TSHZ1 IL4R WNK4 ARHGAP33	1.01e-05	1498	111	21	ctd:C069837
Drug	Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; PC3; HT_HG-U133A	SOX30 NR4A1 PHOX2A ZFHX3 LTBP4 CNOT3 INPP5J	3.60e-05	186	111	7	4271_UP
Drug	ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A	CTC1 TICAM1 LRFN3 RASGRP1 RERE LTBP4 IL4R	3.73e-05	187	111	7	5598_DN
Drug	Estriol [50-27-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A	NCOR1 ZFP36L2 SUGP1 RIPOR1 ZFHX3 IL4R MAST3	4.26e-05	191	111	7	7220_DN
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A	TANC2 PRDM2 VPS13D RERE MMP9 EIF4G3 IL4R	4.55e-05	193	111	7	3412_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	TICAM1 MED1 SUGP1 RIPOR1 WDFY3 IL4R MAST3	4.55e-05	193	111	7	5239_DN
Drug	Etanidazole [22668-01-5]; Down 200; 18.6uM; MCF7; HT_HG-U133A	TICAM1 VPS13D ZFP36L2 NEURL1 SUGP1 RIPOR1 RERE	4.71e-05	194	111	7	6072_DN
Drug	Cyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A	NR4A1 PRDM2 RIPOR1 RERE WDFY3 NFAT5 MAST3	4.71e-05	194	111	7	4411_DN
Drug	H-89, Dihydrochloride; Up 200; 0.5uM; PC3; HT_HG-U133A	LRFN3 MED1 HOXC4 EIF4G1 SUGP1 MMP9 LTBP4	4.71e-05	194	111	7	6921_UP
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A	PPFIBP2 GRB7 PLEKHA6 ZFP36L2 WDFY3 CNOT3 ARHGAP33	4.86e-05	195	111	7	5240_UP
Drug	Procyclidine hydrochloride [1508-76-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A	MUC5B VPS13D SUGP1 RIPOR1 RERE TACC3 MAST3	4.86e-05	195	111	7	4817_UP
Drug	Harmine hydrochloride [343-27-1]; Up 200; 16uM; MCF7; HT_HG-U133A	TBKBP1 SOX30 PRDM2 FOSL1 ZFP36L2 SMO ARHGAP33	4.86e-05	195	111	7	2750_UP
Drug	Myricetin [529-44-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A	PPFIBP2 NR4A1 SUGP1 RERE WDFY3 INPP5J MAST3	4.86e-05	195	111	7	4170_DN
Drug	Cyanocobalamin [68-19-9]; Up 200; 3uM; MCF7; HT_HG-U133A	EPHX2 EP400 PRDM2 ZFP36L2 SUGP1 RIPOR1 LTBP4	5.02e-05	196	111	7	3252_UP
Drug	Mefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A	EPHX2 MED1 PRDM2 SUGP1 DOCK6 NFAT5 IL4R	5.02e-05	196	111	7	1821_DN
Drug	Deptropine citrate [2169-75-7]; Up 200; 7.6uM; HL60; HT_HG-U133A	CTC1 TICAM1 CREB5 FOSL1 NEURL1 RIPOR1 IL4R	5.02e-05	196	111	7	3144_UP
Drug	Tetramisole hydrochloride [16595-80-5]; Down 200; 16.6uM; PC3; HT_HG-U133A	VPS13D HOXC4 ZFP36L2 ZFHX3 WDFY3 IL4R MAST3	5.02e-05	196	111	7	4587_DN
Drug	Methiazole; Down 200; 15uM; MCF7; HT_HG-U133A	CTC1 PPFIBP2 TICAM1 PLEKHA6 ZFP36L2 SUGP1 MAST3	5.02e-05	196	111	7	3878_DN
Drug	Flumethasone [2135-17-3]; Down 200; 9.8uM; HL60; HT_HG-U133A	SNX19 ARAP3 NFATC1 SUGP1 MMP9 NFAT5 IL4R	5.02e-05	196	111	7	2551_DN
Drug	Pizotifen malate [5189-11-7]; Down 200; 9.4uM; PC3; HT_HG-U133A	MUC5B PLEKHA6 CREB5 VPS13D ZFP36L2 SUGP1 ZFHX3	5.02e-05	196	111	7	5072_DN
Drug	Hymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A	TBKBP1 LRFN3 MUC5B SUGP1 RERE NFAT5 LTBP4	5.02e-05	196	111	7	3383_DN
Drug	Quipazine dimaleate salt [4774-24-7]; Up 200; 9uM; MCF7; HT_HG-U133A	PPFIBP2 PLEKHA6 VPS13D ZFP36L2 DOCK6 INPP5J MAST3	5.19e-05	197	111	7	2782_UP
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	EPHX2 PPFIBP2 NR4A1 PLXNB2 HOXC4 CNOT3 MAST3	5.19e-05	197	111	7	3885_DN
Drug	Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; HL60; HT_HG-U133A	TSC22D2 NR4A1 PRDM2 ARAP3 ZFP36L2 WDFY3 NFAT5	5.19e-05	197	111	7	2545_DN
Drug	Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A	GRB7 SUGP1 ZFHX3 RERE WDFY3 IL4R MAST3	5.19e-05	197	111	7	6787_DN
Drug	Isoniazid [54-85-3]; Down 200; 29.2uM; MCF7; HT_HG-U133A	TICAM1 NR4A1 ZFP36L2 SUGP1 RIPOR1 MMP9 IL4R	5.19e-05	197	111	7	7197_DN
Drug	Eserine sulfate, physostigmine sulfate [64-47-1]; Up 200; 6.2uM; MCF7; HT_HG-U133A	GRB7 NR4A1 PRDM2 ZFP36L2 WDFY3 ARHGAP33 MAST3	5.36e-05	198	111	7	2768_UP
Drug	Scoulerine [6451-73-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A	POPDC2 NR4A1 ADRA2B NEURL1 SUGP1 INPP5J ARHGAP33	5.36e-05	198	111	7	2891_UP
Drug	Sulfamonomethoxine [1220-83-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A	TICAM1 GRB7 NR4A1 VPS13D SUGP1 DOCK6 NFAT5	5.36e-05	198	111	7	7200_DN
Drug	Epitiostanol [2363-58-8]; Down 200; 13uM; MCF7; HT_HG-U133A	TANC2 TICAM1 GRB7 VPS13D ZFP36L2 SUGP1 IL4R	5.36e-05	198	111	7	4788_DN
Drug	flufenamic acid; Up 200; 10uM; MCF7; HG-U133A	NR4A1 ZNRF4 CDCP1 NFATC1 SMO TNS4 IL4R	5.36e-05	198	111	7	316_UP
Drug	Etofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A	PLEKHA6 NR4A1 PRDM2 ZFP36L2 SUGP1 NFAT5 LTBP4	5.36e-05	198	111	7	2256_DN
Drug	Hymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A	PRDM2 VPS13D NEURL1 SUGP1 AFF1 RIPOR1 WDFY3	5.36e-05	198	111	7	5684_DN
Drug	Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; PC3; HT_HG-U133A	TSC22D2 CREB5 PHOX2A HOXC4 SUGP1 ZFHX3 TNS4	5.36e-05	198	111	7	2088_UP
Drug	Oxaprozin [21256-18-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A	GDF5 NR4A1 CDCP1 NFATC1 AFF1 WDFY3 MAST3	5.36e-05	198	111	7	4352_UP
Drug	MK-886; Down 200; 1uM; MCF7; HG-U133A	GDF5 PHOX2A KMT2D NFATC1 NFAT5 LTBP4 ARHGAP33	5.53e-05	199	111	7	264_DN
Drug	aspirin, USP; Up 200; 100uM; MCF7; HG-U133A	NR4A1 ZNRF4 SMO TNS4 IL4R ARHGAP33 MAST3	5.53e-05	199	111	7	315_UP
Drug	Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; MCF7; HT_HG-U133A	TICAM1 GRB7 NR4A1 FOSL1 SUGP1 DOCK6 IL4R	5.53e-05	199	111	7	1509_DN
Drug	Griseofulvin [126-07-8]; Down 200; 11.2uM; PC3; HT_HG-U133A	GRB7 SMO TNS4 RERE CNOT3 ARHGAP33 MAST3	5.53e-05	199	111	7	3664_DN
Drug	Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A	PPFIBP2 PLEKHA6 NR4A1 VPS13D ZFP36L2 NEURL1 RIPOR1	5.53e-05	199	111	7	3640_DN
Drug	Imipramine hydrochloride [113-52-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A	NR4A1 PRDM2 FOSL1 VPS13D ZFP36L2 WDFY3 MUC5AC	5.71e-05	200	111	7	1685_UP
Drug	Netilmicin sulfate [56931-57-2]; Up 200; 2.8uM; MCF7; HT_HG-U133A	EPHX2 TBKBP1 PPFIBP2 TSC22D2 VPS13D ZFP36L2 SUGP1	5.71e-05	200	111	7	6005_UP
Drug	rofecoxib; Up 200; 10uM; MCF7; HG-U133A	TICAM1 NR4A1 FOSL1 RIPOR1 WDFY3 EIF4G3 LTBP4	5.71e-05	200	111	7	251_UP
Drug	Lanatoside C [17575-22-3]; Up 200; 4uM; PC3; HT_HG-U133A	GRB7 TSC22D2 NR4A1 CREB5 PRDM2 NFAT5	1.45e-04	162	111	6	3771_UP
Drug	Digoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A	GRB7 TSC22D2 NR4A1 ZFP36L2 NEURL1 NFAT5	1.65e-04	166	111	6	3283_UP
Drug	altersolanol A	ROBO4 NCOA6 RERE	2.70e-04	26	111	3	CID000089644
Drug	Oxyphenbutazone [129-20-4]; Up 200; 12.4uM; MCF7; HT_HG-U133A	EPHX2 TBKBP1 PLEKHA6 NR4A1 FOSL1 DOCK6	3.42e-04	190	111	6	6844_UP
Drug	metacept-1	NR4A1 MMP9	3.49e-04	6	111	2	ctd:C527236
Drug	Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A	PLEKHA6 NEURL1 SUGP1 WDFY3 NFAT5 MAST3	3.52e-04	191	111	6	3605_DN
Drug	2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; MCF7; HT_HG-U133A	TSC22D2 VPS13D SUGP1 WDFY3 CNOT3 ARHGAP33	3.62e-04	192	111	6	3400_DN
Drug	Dimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; MCF7; HT_HG-U133A	TICAM1 SOX30 FOSL1 HOXC4 NFATC1 ZFP36L2	3.62e-04	192	111	6	2807_UP
Drug	rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	EPHX2 PPFIBP2 GRB7 ZNRF4 SUGP1 MUC5AC	3.72e-04	193	111	6	921_UP
Drug	Triamcinolone [124-94-7]; Up 200; 10.2uM; PC3; HT_HG-U133A	TANC2 EPHX2 NID2 TICAM1 SUGP1 WDFY3	3.72e-04	193	111	6	2078_UP
Drug	LY 294002; Up 200; 10uM; PC3; HT_HG-U133A	SOX30 LRFN3 GRB7 MUC5B RERE MUC5AC	3.82e-04	194	111	6	1239_UP
Drug	Tridihexethyl chloride; Up 200; 11.4uM; MCF7; HT_HG-U133A	TBKBP1 ZFP36L2 RIPOR1 DOCK6 LTBP4 ARHGAP33	3.82e-04	194	111	6	3526_UP
Drug	Equilin [474-86-2]; Down 200; 15uM; MCF7; HT_HG-U133A	TBKBP1 TSC22D2 MED1 NFAT5 LTBP4 CNOT3	3.82e-04	194	111	6	3377_DN
Drug	PHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A	CTC1 NR4A1 ZFP36L2 SUGP1 RERE DOCK6	3.82e-04	194	111	6	4559_DN
Drug	Rifampicin [13292-46-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A	GRB7 ZFP36L2 SUGP1 RERE WDFY3 LTBP4	3.82e-04	194	111	6	4126_DN
Drug	Dipyrone [5907-38-0]; Up 200; 12uM; PC3; HT_HG-U133A	MUC5B EFHC2 SYNJ1 NEURL1 ZFHX3 CNOT3	3.82e-04	194	111	6	4310_UP
Drug	Acyclovir [59277-89-3]; Down 200; 17.8uM; MCF7; HT_HG-U133A	GRB7 FOSL1 VPS13D SYNJ1 RERE MAST3	3.82e-04	194	111	6	5278_DN
Drug	Cinchonine [118-10-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A	ZFP36L2 EIF4G1 SUGP1 RERE DOCK6 LTBP4	3.82e-04	194	111	6	4107_DN
Drug	Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A	GRB7 ZFP36L2 RIPOR1 LTBP4 IL4R ARHGAP33	3.82e-04	194	111	6	4804_DN
Drug	Naringenine [480-41-1]; Down 200; 14.6uM; MCF7; HT_HG-U133A	GRB7 MUC5B PLEKHA6 PHOX2A WDFY3 MAST3	3.82e-04	194	111	6	4422_DN
Drug	radicicol; Down 200; 0.1uM; MCF7; HG-U133A	NR4A1 ZNRF4 PRDM2 HOXC4 ZFP36L2 AFF1	3.93e-04	195	111	6	489_DN
Drug	Reserpine [50-55-5]; Up 200; 6.6uM; PC3; HT_HG-U133A	ROBO4 CTC1 GRB7 SYNJ1 SUGP1 DOCK6	3.93e-04	195	111	6	4203_UP
Drug	Iressa; Down 200; 10uM; HL60; HG-U133A	TSC22D2 MED1 NCOR1 ZFP36L2 AFF1 RIPOR1	3.93e-04	195	111	6	541_DN
Drug	Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A	TBKBP1 TSC22D2 HOXC4 SUGP1 WDFY3 INPP5J	3.93e-04	195	111	6	2283_DN
Drug	Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; HL60; HT_HG-U133A	NR4A1 NFATC1 SUGP1 RIPOR1 WDFY3 IL4R	3.93e-04	195	111	6	2173_DN
Drug	Methionine sulfoximine (L) [15985-39-4]; Down 200; 22.2uM; HL60; HT_HG-U133A	TICAM1 PRDM2 SYNJ1 ZFP36L2 WDFY3 DOCK6	3.93e-04	195	111	6	2470_DN
Drug	Fursultiamine Hydrochloride [2105-43-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A	LRFN3 PLEKHA6 ZFP36L2 SUGP1 DOCK6 NFAT5	3.93e-04	195	111	6	4975_DN
Drug	Estropipate [7280-37-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A	EP400 TSC22D2 NR4A1 HEY2 DOCK6 ARHGAP33	3.93e-04	195	111	6	6808_UP
Drug	Dilazep dihydrochloride [20153-98-4]; Up 200; 6uM; HL60; HT_HG-U133A	CTC1 KMT2D AFF1 RIPOR1 WDFY3 MMP9	3.93e-04	195	111	6	2333_UP
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; HL60; HT_HG-U133A	TSC22D2 VPS13D ZFP36L2 SUGP1 WDFY3 EIF4G3	3.93e-04	195	111	6	2358_DN
Drug	Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A	PPFIBP2 TICAM1 SUGP1 WDFY3 EIF4G3 NFAT5	3.93e-04	195	111	6	4398_DN
Drug	Indomethacin [53-86-1]; Up 200; 11.2uM; MCF7; HT_HG-U133A	TSC22D2 PHOX2A VPS13D NEURL1 RIPOR1 IL4R	4.04e-04	196	111	6	7409_UP
Drug	Tranexamic acid [1197-18-8]; Down 200; 25.4uM; MCF7; HT_HG-U133A	TICAM1 LRFN3 PLEKHA6 TSC22D2 NEURL1 SUGP1	4.04e-04	196	111	6	2248_DN
Drug	Lasalocid sodium salt [25999-20-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A	MUC5B SUGP1 AFF1 RERE WDFY3 LTBP4	4.04e-04	196	111	6	3360_UP
Drug	SR-95639A [115767-94-7]; Down 200; 10uM; MCF7; HT_HG-U133A	PLEKHA6 TSC22D2 SUGP1 ZFHX3 DOCK6 IL4R	4.04e-04	196	111	6	3272_DN
Drug	16-phenyl tetranor Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A	TICAM1 LRFN3 NCOR1 ZFP36L2 RERE INPP5J	4.04e-04	196	111	6	7541_DN
Drug	pentamidine isethionate salt; Up 200; 100uM; MCF7; HG-U133A	ROBO4 NR4A1 VPS13D HOXC4 ARAP3 EIF4G3	4.04e-04	196	111	6	639_UP
Drug	Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A	TICAM1 GRB7 TSC22D2 PRDM2 EIF4G1 SUGP1	4.04e-04	196	111	6	4834_DN
Drug	Sulfamethoxypyridazine [80-35-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A	GRB7 FOSL1 VPS13D SUGP1 LTBP4 MAST3	4.04e-04	196	111	6	3409_UP
Drug	Fusidic acid sodium salt [751-94-0]; Up 200; 7.4uM; PC3; HT_HG-U133A	TBKBP1 EFHC2 ADRA2B RERE MMP9 MAST3	4.04e-04	196	111	6	6754_UP
Drug	Fluvastatin sodium salt [93957-55-2]; Down 200; 9.2uM; HL60; HT_HG-U133A	TANC2 FOSL1 VPS13D SUGP1 AFF1 NFAT5	4.04e-04	196	111	6	3032_DN
Drug	Bemegride [64-65-3]; Down 200; 25.8uM; MCF7; HT_HG-U133A	TICAM1 TSC22D2 MED1 ZFP36L2 SUGP1 RERE	4.04e-04	196	111	6	3389_DN
Drug	Solanine alpha [20562-02-1]; Down 200; 4.6uM; MCF7; HT_HG-U133A	NR4A1 HOXC4 SUGP1 HEY2 AFF1 MAST3	4.04e-04	196	111	6	4166_DN
Drug	Betonicine [515-25-3]; Up 200; 25.2uM; HL60; HT_HG-U133A	NR4A1 EFHC2 NFATC1 SUGP1 RERE DOCK6	4.04e-04	196	111	6	2207_UP
Drug	Seneciphylline [480-81-9]; Down 200; 12uM; PC3; HT_HG-U133A	TBKBP1 ZFP36L2 AFF1 ZFHX3 RERE CNOT3	4.04e-04	196	111	6	4238_DN
Drug	Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A	TBKBP1 LRFN3 VPS13D SYNJ1 INPP5J MAST3	4.04e-04	196	111	6	3637_DN
Disease	pancreatic ductal carcinoma (is_marker_for)	MUC5B BMI1 MMP9 MUC5AC IL4R	3.31e-06	61	110	5	DOID:3587 (is_marker_for)
Disease	interstitial lung disease	PPFIBP2 MUC5B NAV1 MUC5AC NOTCH4	5.28e-06	67	110	5	EFO_0004244
Disease	esophagus squamous cell carcinoma (is_marker_for)	GRB7 BMI1 KMT2D MMP9 TET3	8.62e-06	74	110	5	DOID:3748 (is_marker_for)
Disease	cortical surface area measurement	TANC2 GDF5 TICRR PDE3A KIF26B TSC22D2 MBD6 PLXNB2 NCOR1 STAU2 HEY2 NAV1 AFF1 ZFHX3 RERE TACC3 ARHGAP21	9.98e-06	1345	110	17	EFO_0010736
Disease	level of Phosphatidylinositol (18:1_18:1) in blood serum	DOCK7 DOCK6 CNOT3	1.40e-05	13	110	3	OBA_2045159
Disease	Bladder Neoplasm	PRDM2 NCOR1 KMT2D ASXL2 TACC3 MMP9	1.46e-05	140	110	6	C0005695
Disease	Malignant neoplasm of urinary bladder	PRDM2 NCOR1 KMT2D ASXL2 TACC3 MMP9	1.52e-05	141	110	6	C0005684
Disease	Giant Cell Glioblastoma	BMI1 NCOR1 TACC3 MMP9 LTBP4	1.60e-05	84	110	5	C0334588
Disease	level of Phosphatidylinositol (18:0_18:1) in blood serum	DOCK7 DOCK6 CNOT3	3.95e-05	18	110	3	OBA_2045155
Disease	C-reactive protein measurement	NCOA6 PGS1 JMY FOSL1 NCOR1 LRRC25 NEURL1 DOCK7 TNKS1BP1 RERE EIF4G3 NFAT5 IL4R ARHGAP21 ARHGAP33	4.21e-05	1206	110	15	EFO_0004458
Disease	level of Phosphatidylinositol (18:0_18:2) in blood serum	FAM161A DOCK7 DOCK6	6.38e-05	21	110	3	OBA_2045156
Disease	cholangiocarcinoma (is_marker_for)	MUC5B MMP9 MUC5AC IL4R	9.78e-05	64	110	4	DOID:4947 (is_marker_for)
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	PGS1 TSC22D2 DOCK7 SUGP1 AFF1 NFAT5	1.07e-04	200	110	6	EFO_0004611, EFO_0020945
Disease	triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement	PGS1 TSC22D2 JMY DOCK7 SUGP1 AFF1	1.26e-04	206	110	6	EFO_0004612, EFO_0020947
Disease	mucinous adenocarcinoma (is_marker_for)	ZFHX3 MUC5AC	1.37e-04	5	110	2	DOID:3030 (is_marker_for)
Disease	Drugs affecting bone structure and mineralization use measurement	HOXC4 NFATC1 FMN2	1.72e-04	29	110	3	EFO_0009936
Disease	Malignant neoplasm of breast	NID2 NCOA6 XIRP1 TICAM1 GRB7 NCOR1 KMT2D ARAP3 HEY2 NHS AFF1 MMP9 NOTCH4	1.85e-04	1074	110	13	C0006142
Disease	systemic lupus erythematosus	PGS1 KSR2 MED1 RASGRP1 LRRC25 NFATC1 AFF1 SMO RERE TET3 NOTCH4	2.01e-04	799	110	11	MONDO_0007915
Disease	vital capacity	GDF5 NCOA6 PDE3A MED1 JMY CREB5 NCOR1 AFF1 RIPOR1 ZFHX3 NFAT5 LTBP4 VWA5B1 FOXK1	2.05e-04	1236	110	14	EFO_0004312
Disease	Glioblastoma	BMI1 NCOR1 MMP9 LTBP4	2.22e-04	79	110	4	C0017636
Disease	triglyceride measurement, phospholipid measurement	PGS1 TSC22D2 DOCK7 SUGP1 AFF1	2.23e-04	146	110	5	EFO_0004530, EFO_0004639
Disease	Aortic Aneurysm, Thoracic	ROBO4 MMP9	2.86e-04	7	110	2	C0162872
Disease	Aortic Aneurysm, Thoracoabdominal	ROBO4 MMP9	2.86e-04	7	110	2	C0340630
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	PGS1 JMY DOCK7 SUGP1 AFF1 DOCK6	3.08e-04	243	110	6	EFO_0004612, EFO_0020944
Disease	apolipoprotein A 1 measurement	PGS1 XIRP1 PDE3A TSC22D2 DOCK7 AFF1 RIPOR1 TNKS1BP1 DOCK6 CNOT1 FOXK1	3.33e-04	848	110	11	EFO_0004614
Disease	Endometrioma	NCOA6 NR4A1 MED1 NCOR1 RASGRP1	3.51e-04	161	110	5	C0269102
Disease	Endometriosis	NCOA6 NR4A1 MED1 NCOR1 RASGRP1	3.51e-04	161	110	5	C0014175
Disease	cholesteryl esters to total lipids in medium LDL percentage	DOCK7 SUGP1 AFF1	3.57e-04	37	110	3	EFO_0022252
Disease	level of Phosphatidylinositol (16:0_18:2) in blood serum	DOCK7 CNOT3	3.80e-04	8	110	2	OBA_2045153
Disease	alkaline phosphatase measurement	PGS1 USP43 WDR81 TXNDC11 NFATC1 SUGP1 FMN2 MMP9 EIF4G3 NFAT5 CNOT1 ARHGAP21	4.10e-04	1015	110	12	EFO_0004533
Disease	susceptibility to pneumonia measurement	MUC5B PLXNB2 TNS4 MUC5AC	4.85e-04	97	110	4	EFO_0008410
Disease	hemangiopericytoma (is_marker_for)	HEY2 NOTCH4	4.87e-04	9	110	2	DOID:264 (is_marker_for)
Disease	triglycerides in large LDL measurement	DOCK7 SUGP1 AFF1	5.58e-04	43	110	3	EFO_0022319
Disease	pancreatic cancer (is_marker_for)	SMO MMP9 MUC5AC IL4R	5.65e-04	101	110	4	DOID:1793 (is_marker_for)
Disease	interstitial lung disease (is_implicated_in)	MMP9 IL4R	6.08e-04	10	110	2	DOID:3082 (is_implicated_in)
Disease	total lipids in very small VLDL measurement	DOCK7 SUGP1 AFF1	6.38e-04	45	110	3	EFO_0022156
Disease	lipoprotein measurement	PGS1 DOCK7 SUGP1 DOCK6	6.54e-04	105	110	4	EFO_0004732
Disease	free cholesterol in very small VLDL measurement	DOCK7 SUGP1 AFF1	7.25e-04	47	110	3	EFO_0022275
Disease	pulmonary fibrosis	MUC5B MUC5AC	7.41e-04	11	110	2	EFO_0009448
Disease	brain connectivity measurement	GDF5 KIF26B TSC22D2 HEY2 AFF1 TSHZ1 RERE	7.68e-04	400	110	7	EFO_0005210
Disease	Glioblastoma Multiforme	BMI1 NCOR1 MMP9 LTBP4	8.06e-04	111	110	4	C1621958
Disease	developmental disorder of mental health (implicated_via_orthology)	TANC2 PLXNB2 NCOR1	8.20e-04	49	110	3	DOID:0060037 (implicated_via_orthology)
Disease	omega-6 polyunsaturated fatty acid measurement	TBKBP1 DOCK7 SUGP1 AFF1 DOCK6	8.75e-04	197	110	5	EFO_0005680
Disease	intracranial aneurysm (is_implicated_in)	KMT2D MMP9	8.87e-04	12	110	2	DOID:10941 (is_implicated_in)
Disease	cortical thickness	TSC22D2 MBD6 VPS13D STAU2 DOCK7 NAV1 FMN2 AFF1 RERE TACC3 EIF4G3 ARHGAP21	9.20e-04	1113	110	12	EFO_0004840
Disease	phospholipids in very small VLDL measurement	DOCK7 SUGP1 AFF1	9.22e-04	51	110	3	EFO_0022300
Disease	triglycerides in HDL measurement	DOCK7 SUGP1 AFF1	1.03e-03	53	110	3	EFO_0022317
Disease	glycoprotein measurement	DOCK7 SUGP1 ZFHX3 ARHGAP21	1.04e-03	119	110	4	EFO_0004555
Disease	brain measurement, neuroimaging measurement	GDF5 KIF26B TSC22D2 MBD6 SUGP1 HEY2 ZFHX3 TACC3	1.08e-03	550	110	8	EFO_0004346, EFO_0004464
Disease	triglycerides in medium HDL measurement	DOCK7 SUGP1 AFF1	1.09e-03	54	110	3	EFO_0022321
Disease	hypertension (is_implicated_in)	EPHX2 ADRA2B MMP9 WNK4	1.11e-03	121	110	4	DOID:10763 (is_implicated_in)
Disease	cholesteryl ester measurement, high density lipoprotein cholesterol measurement	PGS1 PDE3A TSC22D2 DOCK7 MMP9 DOCK6	1.14e-03	312	110	6	EFO_0004612, EFO_0010351
Disease	total cholesterol measurement, high density lipoprotein cholesterol measurement	PGS1 PDE3A TSC22D2 DOCK7 MMP9 DOCK6	1.19e-03	315	110	6	EFO_0004574, EFO_0004612
Disease	triglycerides in LDL measurement	DOCK7 SUGP1 AFF1	1.21e-03	56	110	3	EFO_0022320
Disease	triglycerides in very large VLDL measurement	DOCK7 SUGP1 AFF1	1.21e-03	56	110	3	EFO_0022325
Disease	triglycerides to total lipids in medium HDL percentage	DOCK7 SUGP1 AFF1	1.21e-03	56	110	3	EFO_0022333
Disease	triglycerides in chylomicrons and extremely large VLDL measurement	DOCK7 SUGP1 AFF1	1.21e-03	56	110	3	EFO_0022316
Disease	cholesteryl esters to total lipids in medium HDL percentage	DOCK7 SUGP1 AFF1	1.21e-03	56	110	3	EFO_0022251
Disease	ventricular septal defect (is_implicated_in)	NFATC1 MMP9	1.22e-03	14	110	2	DOID:1657 (is_implicated_in)
Disease	fatty acid measurement	PLEKHA6 JMY DOCK7 SUGP1 AFF1 DOCK6 NOTCH4	1.26e-03	436	110	7	EFO_0005110
Disease	asthma (is_marker_for)	MUC5B MMP9 MUC5AC IL4R	1.29e-03	126	110	4	DOID:2841 (is_marker_for)
Disease	triglycerides in IDL measurement	DOCK7 SUGP1 AFF1	1.34e-03	58	110	3	EFO_0022149
Disease	hepatoblastoma (is_marker_for)	ZFHX3 SMO	1.40e-03	15	110	2	DOID:687 (is_marker_for)
Disease	triglycerides in VLDL measurement	DOCK7 SUGP1 AFF1	1.41e-03	59	110	3	EFO_0022326
Disease	Malignant neoplasm of skin	SMO MMP9 NOTCH4	1.41e-03	59	110	3	C0007114
Disease	concentration of chylomicrons and extremely large VLDL particles measurement	DOCK7 SUGP1 AFF1	1.41e-03	59	110	3	EFO_0022260
Disease	Skin Neoplasms	SMO MMP9 NOTCH4	1.41e-03	59	110	3	C0037286
Disease	cholesterol in chylomicrons and extremely large VLDL measurement	DOCK7 SUGP1 AFF1	1.48e-03	60	110	3	EFO_0021898
Disease	cholesterol to total lipids in medium HDL percentage	DOCK7 SUGP1 AFF1	1.48e-03	60	110	3	EFO_0022237
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	PGS1 TSC22D2 DOCK7 SUGP1 AFF1	1.55e-03	224	110	5	EFO_0004530, EFO_0008317
Disease	triglycerides in small VLDL measurement	DOCK7 SUGP1 AFF1	1.55e-03	61	110	3	EFO_0022145
Disease	free cholesterol in very large VLDL measurement	DOCK7 SUGP1 AFF1	1.55e-03	61	110	3	EFO_0022274
Disease	autism spectrum disorder (is_implicated_in)	MBD6 MMP9	1.60e-03	16	110	2	DOID:0060041 (is_implicated_in)
Disease	triglycerides in small HDL measurement	DOCK7 SUGP1 AFF1	1.62e-03	62	110	3	EFO_0022158
Disease	cystic fibrosis (is_marker_for)	MUC5B MMP9 MUC5AC	1.62e-03	62	110	3	DOID:1485 (is_marker_for)
Disease	triglycerides in medium LDL measurement	DOCK7 SUGP1 AFF1	1.62e-03	62	110	3	EFO_0022322
Disease	triglycerides to total lipids in very large HDL percentage	DOCK7 SUGP1 AFF1	1.62e-03	62	110	3	EFO_0022339
Disease	total lipids in chylomicrons and extremely large VLDL measurement	DOCK7 SUGP1 AFF1	1.62e-03	62	110	3	EFO_0022306
Disease	total lipids in very large VLDL measurement	DOCK7 SUGP1 AFF1	1.62e-03	62	110	3	EFO_0022313
Disease	free cholesterol in chylomicrons and extremely large VLDL measurement	DOCK7 SUGP1 AFF1	1.62e-03	62	110	3	EFO_0022263
Disease	phospholipids in very large VLDL measurement	DOCK7 SUGP1 AFF1	1.62e-03	62	110	3	EFO_0022299
Disease	free cholesterol to total lipids in medium LDL percentage	DOCK7 SUGP1 AFF1	1.70e-03	63	110	3	EFO_0022283
Disease	phospholipids in chylomicrons and extremely large VLDL measurement	DOCK7 SUGP1 AFF1	1.70e-03	63	110	3	EFO_0022292
Disease	ocular hypertension (biomarker_via_orthology)	SMO MMP9	1.81e-03	17	110	2	DOID:9282 (biomarker_via_orthology)
Disease	triglycerides in small LDL measurement	DOCK7 SUGP1 AFF1	1.86e-03	65	110	3	EFO_0022323
Disease	urate measurement	NCOA6 CRIP3 FOSL1 ALDH16A1 STAU2 NAV1 FMN2 NFAT5 FOXK1 MAST3	1.92e-03	895	110	10	EFO_0004531
Disease	stomach cancer (is_marker_for)	KMT2D SMO MMP9 DOCK6	2.00e-03	142	110	4	DOID:10534 (is_marker_for)
Disease	sinusitis (is_marker_for)	MUC5B MMP9	2.03e-03	18	110	2	DOID:0050127 (is_marker_for)
Disease	MYELODYSPLASTIC SYNDROME	CTC1 BMI1 SLX4	2.03e-03	67	110	3	C3463824
Disease	uric acid measurement	PLEKHA6 NFATC1 SUGP1 NAV1 ASXL2 NFAT5 GLIS1 FOXK1	2.06e-03	610	110	8	EFO_0004761
Disease	FEV/FEC ratio	NID2 PDE3A SOX30 KSR2 HOXC4 FCGBP NFATC1 NEURL1 NAV1 RIPOR1 ZFHX3 LTBP4	2.11e-03	1228	110	12	EFO_0004713
Disease	triglycerides in very small VLDL measurement	DOCK7 SUGP1 AFF1	2.12e-03	68	110	3	EFO_0022144
Disease	triglycerides to phosphoglycerides ratio	DOCK7 SUGP1 AFF1	2.12e-03	68	110	3	EFO_0022327
Disease	neuroimaging measurement	KIF26B KSR2 TSC22D2 MBD6 PLXNB2 NCOR1 SYNJ1 HEY2 AFF1 RERE TACC3	2.18e-03	1069	110	11	EFO_0004346
Disease	Prostatic Neoplasms	PPFIBP2 GRB7 NCOR1 KMT2D ZFP36L2 ZFHX3 MMP9 CNOT3	2.19e-03	616	110	8	C0033578
Disease	Malignant neoplasm of prostate	PPFIBP2 GRB7 NCOR1 KMT2D ZFP36L2 ZFHX3 MMP9 CNOT3	2.19e-03	616	110	8	C0376358
Disease	rheumatoid arthritis (is_marker_for)	TAB3 MMP9 NOTCH4	2.21e-03	69	110	3	DOID:7148 (is_marker_for)
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	TSC22D2 SNX19 HOXC4 ZFHX3 RERE NFAT5	2.47e-03	364	110	6	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	glaucoma (is_marker_for)	MMP9 MUC5AC	2.50e-03	20	110	2	DOID:1686 (is_marker_for)
Disease	Osteoarthritis of hip	GDF5 SMO	2.50e-03	20	110	2	C0029410

Protein segments in the cluster

Peptide	Gene	Start	Entry
APPCPRPLPTSSTSS	EP400	691	Q96L91
PPRPSSCLLTPSPQN	nan	251	Q9N2J8
PTQTPGFPTQPPCTS	ARAP3	1521	Q8WWN8
GFPTQPPCTSSPPSS	ARAP3	1526	Q8WWN8
PVPRPCLHSATPSTP	CTC1	701	Q2NKJ3
PPTLVSNLPPASPCA	ALDH16A1	381	Q8IZ83
VCPPSPPTICSRAPT	CDCP1	771	Q9H5V8
PQSLQSPSSIPPVCP	CDCP2	391	Q5VXM1
LPSPTSPCPSPVLVR	RASGRP1	706	O95267
PVSPASACSPPLQQP	ADRA2B	316	P18089
TSPPISCVPSSQPSA	CDAN1	216	Q8IWY9
TPPVPPTPAVSGACT	ASXL2	776	Q76L83
SSSPIPPSPANCTTE	CNOT3	266	O75175
CPTSPPPVSSAPLSS	MUC5B	4986	Q9HC84
SPAAPVSSTPTPTPC	MUC5B	5271	Q9HC84
CSAPSPSTPSFQPPQ	NR4A1	136	P22736
PESSPPASPVPACSQ	CREB5	456	Q02930
PSTGSVAPCVPPLST	HEY2	241	Q9UBP5
TTTPQPTAPPTVCPT	MMP9	456	P14780
CVLSAPQPGPPTSSV	MBD6	696	Q96DN6
TPPTCCVPTRLSPIS	GDF5	461	P43026
CSVTINPLPSPLPPT	JMY	796	Q8N9B5
APKPQVAVPSCPSTP	LRRC25	226	Q8N386
ASPCSPPPLSNIPTL	KIF26B	216	Q2KJY2
SAICPSNPPLPSSTS	KIAA2026	2021	Q5HYC2
TPPSPLHPSPQCTRQ	KSR2	541	Q6VAB6
PSTSSCLPSPSTPVQ	BMI1	266	P35226
CLPSPSTPVQSPHPQ	BMI1	271	P35226
ENFTSVSCKPPSPPP	EFHC2	371	Q5JST6
AVICNSPSSIPVTPP	PLXNB2	571	O15031
PLLSPAVPQVTSPPC	PGS1	56	Q32NB8
PLSSPCSSPLQGTPA	PDE3A	521	Q14432
LLPQQVSAPPSSSCP	NFATC1	821	O95644
ASSPPQSATPSPCPR	LRFN3	16	Q9BTN0
CPSTTLPPAPATSPS	MUC5AC	4826	P98088
TPSSPILCTQPAGVP	NFAT5	431	O94916
SIPNPFPELCSPPSQ	GRB7	66	Q14451
CSSPTVGPPPLPQKS	PPFIBP2	361	Q8ND30
SSTKPVPLNCPSPVP	MTMR4	991	Q9NYA4
VQLPSPPCTSSPVVP	NCOA6	1741	Q14686
SQPGTTPACIPTVAP	NID2	1076	Q14112
AAQSPCSVPSQVPTP	ARHGAP33	1016	O14559
PPASPTQSPDNLTCT	IL4R	471	P24394
LLNTPAPLPTSCNPS	EPHX2	221	P34913
CCPLSPPASPSPSVS	DOCK6	1061	Q96HP0
LPCSLLTPPASPSPS	DOCK7	1136	Q96N67
SPCPASCPSPAPLTT	FCGBP	1961	Q9Y6R7
PASCPSPAPLTTPAV	FCGBP	4366	Q9Y6R7
ASASPSPAPPACSQP	HOXC4	106	P09017
VPSPTGTISVPNSCP	FOXK1	241	P85037
CTTPLSPSSFSPPRP	CRIP3	86	Q6Q6R5
CPSESPVPIAPTAQP	EIF4G1	386	Q04637
TSSIPPSPLACPPIS	MAST3	1181	O60307
RCLNPVPAVPSPSPS	LTBP4	86	Q8N2S1
LCSPTSLTIPQPLSP	ESRG	91	Q1W209
CVLGLPPTSPASSSP	GLIS1	66	Q8NBF1
PVPCNCNPPVPTVSS	FAM161A	506	Q3B820
NSCNIPSPPPLPCTE	FMN2	851	Q9NZ56
AGSCPPSPPSVISSI	SALL3	826	Q9BXA9
CIPAPITPSTVPSFP	EIF4G3	401	O43432
PHITPAPSQCSTPPT	MED1	736	Q15648
APSQCSTPPTTYPQP	MED1	741	Q15648
TSGTSSPPAPCRPVP	FOSL1	186	P15407
TPDVCPSSPALQTPS	PRDM2	941	Q13029
PCPSPLSNATAQSPL	PRDM2	1006	Q13029
PESAPAQCKVPSPPT	PCARE	1061	A6NGG8
SPSLPSPPVSLDPCA	IRX3	321	P78415
PLPSCFTPSPAPILN	NAV1	836	Q8NEY1
PTPPPVSESQCSRSP	SYTL3	156	Q4VX76
TSLPTSCPGSEPVPT	TACC3	496	Q9Y6A5
PVTAAPSQPPTTCSS	TSC22D2	146	O75157
GPSCTPSPSPRVIPN	TAB3	436	Q8N5C8
CQSPTISEGPVPSLP	SYNJ1	1051	O43426
CPSQTSETIPPAASP	NHS	641	Q6T4R5
TPPTPIACAPSAVNQ	NCOR1	2396	O75376
VPSLPPSIPSSCASI	PHF12	621	Q96QT6
TLCTGPSSQAPPQPP	SMCR5	41	Q8TEV8
PPASSPCSTLPPIST	TANC2	141	Q9HCD6
PITPPTCPSTSTPPA	RERE	1046	Q9P2R6
SASNIPIPPPCLTPS	NOTCH4	1961	Q99466
VSPCPRSAPIPQASP	SOX30	571	O94993
IPILSPCSPPSPQAS	ROBO4	751	Q8WZ75
VPNSDSQPPPSCLTT	SLX4	181	Q8IY92
SQPPPSCLTTAVPSP	SLX4	186	Q8IY92
IRPQTPPPQTPSSCL	SLX4	1311	Q8IY92
PPPQTPSSCLTPVSP	SLX4	1316	Q8IY92
SCGSSPLNITSTPPP	ARNTL	516	O00327
PSPCIASTGTPSPLS	AFF1	1091	P51825
PEVVASPLVPCPSTP	C11orf91	116	Q3C1V1
PATNTTCTATVPPQP	CNOT1	1341	A5YKK6
TTCPASSTPAPTIIP	SUGP1	351	Q8IWZ8
PPCIQTSPDPRLSPS	INPP5J	266	Q15735
VQCATPSPPTSPASP	PLEKHA6	1011	Q9Y2H5
PCPSLPQVPDSPIFT	USP43	756	Q70EL4
ESEVCPVPTNSPSPP	ZBTB21	971	Q9ULJ3
PTPANCSTAAPPTPA	nan	56	Q8N377
VNSSPESPSCPAPPT	TICRR	1216	Q7Z2Z1
ASLSCPVPSTPPELS	TICRR	1351	Q7Z2Z1
QIPPCLTSESSLPSP	WDFY3	786	Q8IZQ1
IPSLPCSPASTPTSP	NEURL1	456	O76050
SPTPPCSPVQPSKQL	STAU2	486	Q9NUL3
PPSSSGPPCPALTST	SAPCD2	316	Q86UD0
LSPRPPNSPSISIPC	TNS4	221	Q8IZW8
TTSPNTKPCPPTPTT	TICAM1	341	Q8IUC6
TCSPTPDSTASLPPP	PHOX2A	181	O14813
SQASPCPAVTPSAPS	TNKS1BP1	326	Q9C0C2
ASCLPPPVGPSSTQT	ZNRF4	51	Q8WWF5
PPQATPTSLQQTPPC	POPDC2	296	Q9HBU9
PTSLQQTPPCSTPPA	POPDC2	301	Q9HBU9
QTPPCSTPPATTNFP	POPDC2	306	Q9HBU9
STPQASCPLPEALSP	TET3	376	O43151
QCSPVPPTPSTPPQS	nan	36	Q1RN00
PCPASAPEQPSVPTS	SNX19	276	Q92543
TLVSNPFCPEPSPPQ	SMO	731	Q99835
PAQLPDPPTITASPC	TXNDC11	436	Q6PKC3
TVPVTPTAGSCQPSP	nan	46	Q6ZR54
PSIATVPPCLTTSAP	ARHGAP21	836	Q5T5U3
TLPGTDSLPCSPPVS	RIPOR1	701	Q6ZS17
DSPTSRTPPPPSCSS	ZFP36L2	281	P47974
PCPSPQQRRSPASPS	TBKBP1	376	A7MCY6
QCSVQPEPAPPSASP	XIRP1	1726	Q702N8
SSSTPEFPVPLSQCP	WNK4	866	Q96J92
KESSAPTPTPPTCPV	TSHZ1	151	Q6ZSZ6
PPPCPSQLLSPFSSV	WDR81	856	Q562E7
SPSPLAFCPCPPVNS	ZNF683	166	Q8IZ20
TPSPQLCTSSPPRHP	VWA5B1	1101	Q5TIE3
QCPLPQSSPSPSQLS	ZFHX3	2491	Q15911
TSSPCPDSPLPPLST	VPS13D	1566	Q5THJ4
SLVPQNSPPSQCSPP	KMT2D	1031	O14686
NSPPSQCSPPALPLS	KMT2D	1036	O14686